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Abstract 
 
Difficulties performing a concurrent cognitive task while walking have been reported in 
several  neurological  conditions.  Such  difficulties  may  have  significant  functional 
consequences,  including  increasing  the  risk  of  falls.  A  systematic  review  of  studies 
investigating  the  effect  of  a  concurrent  cognitive  task  on  walking  in  neurological 
conditions was conducted. The aims of the review were 1) to determine the effect of a 
concurrent cognitive task on walking, 2) to determine the effect of titrating task demand on 
dual-task  performance  and  3)  develop  recommendations  for  future  research.  Forty-one 
articles were identified through electronic and hand search. Sixteen articles met inclusion 
criteria.  Studies  were  rated  using  quality  criteria,  effect  sizes  were  calculated  and  a 
narrative  review  was  conducted.  Fifteen  out  of  16  studies  reported  a  disproportionate 
decrement in walking ability, relative to healthy controls, when performing a concurrent 
cognitive  task  in  neurological  conditions;  including  Alzheimer’s  disease,  Parkinson’s 
disease, stroke and brain injury. It was only possible to calculate effect size for half of the 
studies; the median effect size was 0.77. Several methodological issues with the literature 
were  identified.  Performing  a  concurrent  cognitive  task  while  walking  has  a 
disproportionate effect in a range of neurological conditions. Recommendations are made 
for future research.  
 
Key words: Adult, attention, memory, neuropsychological tests, gait, nervous system 
disorders 
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Introduction 
         In everyday life we frequently do more than one thing at any one time; e.g. having a 
conversation while walking, crossing a busy road, and navigating a supermarket. Dual-
tasking refers to this ability to do two things at once. Dual-task paradigms compare 
people’s performance when tasks are performed alone (single task) and when two tasks are 
performed simultaneously (dual-task). The decrement in dual-task performance, compared 
to single task performance, is thought to reflect the attempt to share limited capacity 
between the two tasks. Investigations using a dual-task paradigm further our understanding 
of the organisation of cognitive resources in the brain (Della Sala & Logie, 2001) and the 
effect of neurological conditions such as Alzheimer’s disease, stroke, brain injury and 
Parkinson’s disease on divided attention. This understanding is important because if our 
ability to do two things at once is impaired, then this has implications for our functioning 
in everyday life. Though activation studies implicate the pre-frontal and anterior cingulate 
cortices in dual-tasking (Dreher & Grafman, 2003), it is unclear which anatomical lesions 
may be responsible for deficits in dual-task performance. 
Different types of dual-task combinations are possible; for example demands of both 
tasks may be principally motor or principally cognitive, or tasks may include both motor 
and cognitive demands. One type of dual-task is performing a simultaneous cognitive task 
while walking, something people are frequently required to do in everyday life.  In the past 
walking was generally considered to be an automatic process involving minimal attentional 
resources (Woollacott & Shumway-Cook, 2002). Recent research however has shown that 
even in healthy adults walking can be attentionally demanding when a secondary task is 
performed simultaneously (Woollacott & Shumway-Cook, 2002). In healthy adults the 
dual-task effect is small and occurs only when quite complex secondary additional tasks 
are performed, though the dual-task effect increases with age.  
Adults with a variety of neurological conditions; including Alzheimer’s disease 
(Cocchini et al., 2004), Parkinson’s disease (Yogev et al., 2005), stroke (Hyndman et al.,   5 
2006 and Kemper et al., 2006) and acquired brain injury (Haggard et al., 2000) appear to 
be disproportionately impaired while walking and simultaneously performing a cognitive 
task, compared to healthy age-matched controls. For example reduced step length and 
slower speed have been reported in Parkinson’s disease (Rochester et al., 2004) and 
increased stride duration and poorer cognitive performance are reported in brain injury 
under dual-task conditions (Haggard et al., 2000). Dual-task walking may therefore 
uncover deficits not apparent under single task conditions, and may be a more sensitive 
assessment of everyday walking ability in these neurological groups. This may have 
implications for the assessment and rehabilitation of walking in physiotherapy settings in 
brain injury and other neurological conditions (Haggard et al., 2000). 
Lundin-Olsson and colleagues reported that older adults who tended to stop walking 
while talking were more likely to suffer falls (Lundin-Olsson et al., 1997). Subsequent 
studies have suggested that dual-tasking does not provide independent prediction of falls 
but significantly affects gait parameters associated with falling (Yogev-Seligman et al., 
2008). It has been suggested that this dual-tasking difficulty explains the high risk of falls 
in Alzheimer’s disease (Cocchini et al., 2004), despite the fact that gait and motor function 
are relatively spared early in the disease (Sheridan  & Hausdorff, 2007).  
Difficulties performing a concurrent cognitive task while walking may be affected 
both by motor and cognitive factors in neurological conditions.  Sensory/motor deficits as a 
direct consequence of disease interfere with gait in some conditions, such as Parkinson’s 
disease or stroke. Mulder and colleagues suggest the motor system comprises both a fast 
mode, involving the automatic control of over-learned movements, and a slow mode, 
involving direct cognitive control of newly learned or complex movements. They postulate 
that when the motor system is damaged control of movement is primarily directly 
cognitive and via this slow mode of control (Mulder et al., 2002). Walking therefore 
becomes an attention demanding task.   6 
There are therefore three possible explanations for the development of a dual-tasking 
deficit. One is that a basic deficit in motor functioning means that motor tasks require more 
conscious attention for successful performance, as described above, and so the limited 
capacity working memory system is overloaded in the dual-task situation. Another 
possibility is that in neurological conditions working memory capacity is reduced, so that 
is overloaded by previously normal loads of motor and cognitive content. A third 
possibility is that rather than basic working memory capacity being the problem, there is a 
deficit in the attention control system that allocates attention between concurrent demands 
(Logie et al., 2004).  Baddeley and Hitch’s model of working memory suggests that a 
central executive is responsible for the division of attention between concurrent tasks 
(Baddeley & Hitch, 1974). From this model a difficulty performing two concurrent tasks is 
seen as due to a deficit in the ability to allocate attentional resources to competing 
demands, rather than due to insufficient attentional capacity. Deficits in divided attention 
are well documented in Alzheimer’s disease (Binetti et al., 1996), Parkinson’s disease 
(Dubois & Pillon, 1997) and brain injury (Park et al., 1999). Holtzer and colleagues (2005, 
2006) reported that in healthy older adults dual-task performance decrement is predicted 
both by speed/executive attention factors and memory factors. 
It has been argued that in studying dual-tasking it is important to control for the effect 
of task demand impacting on dual-tasking when comparing a patient group with a healthy 
control group (Cocchini et al., 2004 and Yogev et al., 2008). In order to determine whether 
dual-tasking difficulties are specifically caused by a divided attention/dual-tasking process 
impairment it is suggested that it is necessary to titrate tasks according to performance 
under single task conditions. Some studies have attempted to do this, while in other studies 
this issue is not addressed. Cocchini and colleagues (2004) assessed ability to perform a 
digit span task under single task conditions. The digit span task involves listening to 
sequences of numbers of varying length and repeating them, e.g. 2-5-1, 5-4-9-2-7-8. Under 
titrated dual-task conditions participants were required to complete the digit span task at   7 
their individual span length as previously assessed, i.e. some individuals listened to 
sequences five digits long while others heard sequences seven digits long. In a fixed 
demand condition all participants would have heard sequences seven digits long, as this is 
the average digit span in adults. Titrating dual-task demand to single task performance has 
the advantage of making it clearer whether a divided attention deficit or task demand is 
responsible for difficulties dual-tasking in neurological conditions, though may be less 
clinically relevant to the extent that everyday conditions are not titrated to individual 
performance levels.  
Two other factors may influence the performance of a concurrent cognitive task 
while walking; the prioritisation of performance during dual-tasks and the effect of 
instruction on task performance. Bloem and colleagues (2001) suggest that healthy adults 
prioritise performance on walking over cognitive performance, while a recent review of 
dual-tasking in Parkinson’s disease suggest that these patients maintain cognitive 
performance at the cost of a reduction in walking performance (Bloem et al., 2006).  
Huitema et al. (2006) report that post-stroke patients also fail to prioritise walking during 
dual-tasking. Canning  (2005) reports that instructing participants to direct their attention 
to walking improved walking performance while concurrently carrying a tray in 
Parkinson’s disease. 
Research on the effect of performing concurrent cognitive tasks on walking in 
neurological conditions is spread across a variety of literatures; including physiotherapy, 
gait and cognition; and has employed a number of methodologies. For example some 
studies have used simple measures of walking, such as number of steps walked within a 
time limit, while others have used measures such as stride variability and stride duration. 
Different studies have also employed different cognitive tasks. The extent to which a 
cognitive task is attentionally demanding will have an effect on study outcomes. This 
makes it difficult to assess or summarise the findings of the literature. Without an adequate   8 
summary of the literature and its findings it is difficult to evaluate competing explanations 
of any possible dual-task effects.  
There has been one review of the effect of a concurrent cognitive task on walking 
(Woollacott & Shumway-Cook, 2002).The review covers studies of dual-tasking in both 
healthy adults and adults with neurological conditions and is helpful in summarising a new 
and developing literature. It concludes that the attentional demands of dual-tasking varied 
depending on the complexity of the task and the type of secondary task being performed. 
The review is now several years old and has some limitations; it is not systematic, both 
healthy and neurological populations are included and it does not address the task demand 
issue or the methodological issues of the literature. There is a more recent review of 
walking and a concurrent task (either cognitive or motor) in patients with Parkinson’s 
disease (Bloem et al., 2006), though this is not systematic nor does it address the above 
issues in the literature.  
The aims of this review are to determine the effect of a concurrent cognitive task on 
walking in people with neurological conditions and to determine the effect of titrating task 
demand on dual-task performance. It is hoped that this will allow a more complete analysis 
of possible explanations for performance on  concurrent cognitive and walking tasks in 
neurological conditions and will lead to suggestions for future research in the area.  
 
 
Method 
A systematic review was conducted. All studies investigating the effect of a 
concurrent cognitive task on walking in neurological populations over 18 years of age were 
eligible for inclusion.  
Search Strategy and Sensitivity Analysis 
Computerised databases searched were MEDLINE (1950 to Week 1 October 2007), 
Cochrane Database of Systematic Reviews (Issue 3, 2007), British Nursing Index and   9 
Archive (1985 to September 2007), CINAHIL (1982 to Week 1 October 2007) and 
PsycINFO (1806 to Week 2 October 2007). Search terms used were [dual task] AND 
[walking] OR [gait] AND [neurological] OR [Alzheimer’s] OR [Parkinson’s] OR 
[dementia] OR [Multiple Sclerosis] OR [Stroke] OR [Brain Injury] OR [cognitive]. Other 
search terms were used, including divided attention, but identified no further articles. On-
line abstracts were reviewed and copies of potentially eligible articles were obtained. 
Reference lists of included articles were hand searched for additional articles. Further 
electronic search using first authors of included articles was conducted and all first authors 
of included articles were contacted via email for details of any further articles, though no 
extra articles were identified . 
Data Extraction 
Exclusion criteria were (1) performance of the neurological group was not compared 
to a healthy control group, (2) single and dual-task performance were not compared, (3) the 
paper involved case report rather than experimental study, (4) the motor task was not 
walking and (5) the paper was a review paper rather than original research (see Figure 1).   
Figure 1 outlines the article selection process for the review. Electronic searches 
identified 28 relevant studies and hand search identified a further 13. Of these, nine were 
excluded as the motor task was not walking, and a further 16 were excluded for other 
reasons (see Figure 1). Sixteen research papers, published between 1997 and 2007, met the 
inclusion criteria. 
[INSERT FIGURE 1 HERE] 
Quality Criteria 
A quality criteria protocol was compiled (see Table 1) based on the Scottish 
Intercollegiate Guidelines Network (SIGN) Methodology Checklist 4: Case-control studies 
(SIGN, 2007), the Consolidated Standards of Reporting Trials (CONSORT) (Altman et al., 
2001), York Centre for Reviews and Dissemination (YCRD) guidelines (YCRD, 2007)  
and the criteria used by Ellis and colleagues (1996). The quality criteria covered six   10 
methodological areas; participants, confounding factors, study design, study description, 
results and overall assessment (Table 1). Each question on the protocol was answered 
‘yes’, ‘partial’, ‘no’ or ‘not reported’ with scores of 2, 1, 0, and 0 respectively. The total 
maximum possible score was 38. Two raters assessed the quality of each paper 
independently using the protocol. Agreement was 87%. A third party arbitrator was 
available to resolve any disagreements. The quality ratings of included studies are outlined 
in Table 2. A narrative review of the included studies was also conducted in order to 
identify issues unique to this particular literature. 
[INSERT TABLE 1 HERE] 
Effect Sizes   
Effect sizes were calculated for each variable under investigation within each 
particular study, wherever possible. Effect size was calculated regardless of whether a 
statistically significant difference was found for that variable under dual-task conditions.  
 
 
Results 
Studies Included in Review 
Sixteen papers (17 studies as one paper included two studies) were included in the 
review. Details of the included studies, as well as the quality rating and effect size for each 
study, are outlined in Table 2. Studies involved participants with four different 
neurological conditions; Alzheimer’s disease (five studies), brain injury (four studies), 
Parkinson’s disease (six studies) and stroke (two studies). 
[INSERT TABLE 2 HERE]  
Four out of five Alzheimer’s disease studies reported a disproportionate decrement in 
patient performance, relative to controls, in the dual-tasking condition. One study reported 
a greater combined decrement (of both walking speed and cognitive performance) in   11 
patients. Four out of five of these studies did not measure the effect of dual-tasking on 
performance on the cognitive task.  
Three out of four brain injury studies reported disproportionate dual-task effects for 
patients on various walking parameters.  Three out of four brain injury studies measured 
cognitive performance. Of these three, one found disproportionate dual-task effects in 
patients on the number of errors on cognitive tasks.  
All of the Parkinson’s disease studies reported greater dual-task effects for patients 
on several different walking parameters. Half of the studies measured cognitive 
performance. Of these, all found disproportionate dual-task effects on cognitive tasks in 
patients; primarily in slower response rate and increased error rate. 
Both stroke studies reported disproportionate dual-task effects for patients on both 
walking and cognitive performance.  
Quality Ratings 
The quality ratings of the studies ranged from 20/38 to 30/38, with a median score of 
25/38. Scores of each study on each quality criterion are available in Appendix B1. Few 
studies reported the percentage of patients and controls that participated, and none of the 
studies compared participants and those who declined to participate. Only one study 
reported how sample size was determined. Studies with the lowest overall scores tended 
not to have reported exclusion criteria, whether the same criteria were applied to cases and 
controls or to have addressed multiplicity of analyses. Other common reasons for losing 
points were not taking potential confounders into account and not comparing patients and 
controls on demographic and clinical characteristics. In particular many studies took 
account of age and education as potential confounders, but few controlled for fatigue.  
It was difficult to determine whether study quality affected findings, due to study 
differences in factors such as patient group, outcome measures and methodology (see 
below). For example 15 studies used speed or a proxy of speed (e.g. time, distance) as an 
outcome measure. Of these seven reported a differential dual-task decrement in the patient   12 
group and eight reported no difference. There was no systematic discrepancy in quality 
ratings between studies that reported a difference and those that did not. However, studies 
differed with respect to time or distances walked, cognitive task used and patient group.  
Effect Sizes 
It was not possible to calculate effect sizes for eight studies. This was primarily 
because studies reported means and standard deviations for dual-task performance and for 
single-task performance, but not means and standard deviations for differences between 
dual and single task performances. For the remaining nine studies effect sizes were 
calculated for each outcome measure, therefore it was possible to have several different 
effect sizes for the same study. Calculated effect sizes ranged from 0.46 to 1.2, with a 
median effect size of 0.77. This is approaching a large effect size (Cohen, 1988). 
Methodological Issues 
A number of methodological issues make it difficult to compare included studies. 
First, there is wide variability in the walking tasks employed in the studies (see Table 3).  
[INSERT TABLE 3 HERE] 
Five studies employed distance walked during a set time, ranging from 30 seconds to 
5 minutes, as the measure of walking. Twelve studies employed time to walk a particular 
distance, ranging from 5 metres to 11 metres (with one study not specifying the distance), 
as the measure of walking. There are two difficulties with this variability. Greater distances 
or greater time spent walking may be more taxing for patients and therefore these studies 
may be more likely to show a dual-task effect, though it is unclear how much of this may 
be due to the greater effects of fatigue in the patient groups. Patient groups may also be at a 
disadvantage in studies employing a fixed distance as the measure of walking. Patient 
groups, compared to healthy controls, may be slower on even simple walking. This means 
that they will be walking for longer than healthy controls on all tasks involving walking. In 
comparison, studies that utilise a fixed time as the measure of walking ensure that all 
participants are dual-tasking for the same duration.    13 
A further difficulty comparing studies is that the studies have measured different 
parameters of walking and it may be that some of these are more sensitive to the effects of 
dual-tasking on walking than others (see Table 4). Some studies have used basic measures 
of walking such as time, distance, velocity or number of steps. Other studies have used 
electronic equipment, such as electronic walkways, to measure more complex parameters 
such as stride time, stride length, step width and stride and swing variability. Table 4 
summarises the parameters of walking used in different studies. 
[INSERT TABLE 4 HERE] 
Thirdly, there is variability in the cognitive tasks employed by studies (see Table 3). 
Six studies employed some form of verbal fluency task, either reciting names in a 
particular category or producing exemplars from a category. One study employed a digit 
span task. Seven studies used tasks which involved a level of mental manipulation; such as 
subtracting serial numbers or reciting the days of the week backwards. One study 
employed the Stroop, which was projected onto a wall while participants walked. Two 
studies required participants to answer ‘autobiographical questions’, though the nature of 
the questions is unclear. Two studies required participants to repeat sentences, while one 
study required participants to learn and recall a seven item shopping list. Some studies 
used more than one cognitive task, therefore the total cognitive tasks exceeds the total 
number of studies. 
The extent to which cognitive tasks are attentionally demanding may influence the 
size of any dual-task effect found. It is questionable whether some of the tasks employed 
were difficult enough to induce a dual-task effect. Two studies have compared cognitive 
tasks of varying levels of difficulty. Campbell and colleagues (2003) found that a dual-task 
effect was evident in their high demand task (days of the week backwards) but not in their 
low demand task (repeating sentences). Similarly, Yogev and colleagues (2005) found a 
greater dual-task effect during a complex listening task compared to a simple listening 
task.   14 
Fourth, six studies did not measure performance on the cognitive task (Camicioli et 
al., 1997; Campbell et al., 2003; Catena et al., 2007; Parker et al., 2005; Rochester et al., 
2004).  Of the 10 studies that did measure performance on the cognitive task, six found that 
dual-tasking had a differential effect. The failure of some studies to measure cognitive task 
performance makes it difficult to comprehensively evaluate dual-task decrements in these 
studies. In dual-task conditions some participants may sacrifice performance on the 
walking task, while others maintain walking performance but sacrifice performance on the 
cognitive task. If performance on both tasks is not evaluated then a full picture of 
performance under dual-task conditions will not be achieved.  
A related issue is the use of combined decrement scores. Cocchini and colleagues 
(2004) calculated combined decrement scores in order to evaluate dual-task effects. The 
combined decrement score is a single score for the overall combined decrement for both 
dual-tasks (cognitive and walking). It averages the percentage change in each task under 
dual-task, compared to single task, conditions to give an overall percentage change score. 
It assumes both tasks have equal importance. This approach takes into account any 
variability in the relative emphasis that different participants give the two tasks when 
performing them simultaneously (Nebes et al., 2001). That is, a participant may trade off 
performance on one of the tasks in order to maintain better performance on the other task. 
Thus two participants may have a similar combined dual-task decrement, though one may 
have sacrificed performance on the cognitive task while the other has sacrificed 
performance on the walking task. In the studies reviewed here only one study adopted this 
approach, and as previously mentioned several did not measure cognitive task 
performance, making it more difficult to compare dual-task effects across participants and 
across studies. 
There is another issue in comparing the dual-task performance of a patient population 
to that of healthy control participants: differences in single-task performance can confound 
interpretation of dual-task performance. Those participants who have difficulty carrying   15 
out a task by itself will find the dual-task condition proportionately more difficult than will 
subjects for whom the single-task condition is fairly easy, because the poorer performers 
are operating closer to their performance limit under the single-task condition (Baddeley et 
al., 1986).  Some studies have dealt with this problem by titrating the difficulty level of 
each cognitive task to the individual’s performance level under single-task conditions 
(Logie et al., 2004; Nebes et al., 2001).  This ensures that the amount of decrement 
produced when subjects have to combine the two tasks is not confounded by individual 
differences in performance on the single-task condition. In this review however, only one 
study titrated cognitive task difficulty, and found no difference between dual and single 
task performance (Cocchini et al., 2004). 
 
 
Discussion 
The findings of this review suggest that a concurrent cognitive task has a 
disproportionate effect on walking in people with Alzheimer’s disease, Parkinson’s 
disease, brain injury and stroke. Traditionally walking has been considered an automatic 
task, requiring few higher cognitive resources (Woollacott & Shumway-Cook, 2002). The 
findings indicate that there are significant demands on attentional resources when walking 
whilst performing a concurrent cognitive task. There is a disproportionate effect in several 
neurological conditions, with a variety of both walking and cognitive parameters 
disproportionately affected under dual-task conditions. This has a number of real life 
implications for individuals living with these conditions. We can expect that for these 
individuals, performance on many everyday tasks will be poorer where concurrent 
cognitive and walking demands are present.  
 It has been suggested that disproportionate impairment on dual-tasks is related to the 
risk of falls (Yogev et al., 2005; Lundin-Olsson et al., 1997; Bloem et al., 2006). Falls are 
common in many neurological diseases and are difficult to predict as clinical tests assess   16 
single components of postural control while everyday falls mechanisms are typically more 
complex (Bloem et al., 2006). Dual-task walking may therefore be a more sensitive 
assessment of walking ability in these neurological groups. The relative contribution of 
dual-task effects in predicting falls is still under investigation. Recognition of dual-task 
effects and their impact on fall risk may lead to the development of strategies, including 
physiotherapy and cognitive rehabilitation strategies, which these groups could use to 
ensure safer walking and to minimise the impact of dual-task demands. A recent study 
using randomised control trial methodology reported that a cognitive-motor training 
programme, involving walking with simultaneous cognitive tasks of gradually increasing 
demand, may lead to improvements in walking and talking in people with brain injury 
(Evans et al., submitted). 
The current review identified several methodological issues. It was possible to 
calculate effect size for only half of the studies, and these effect sizes were approaching 
large. Considerable variability in the methods studies used, particularly in the types of 
tasks and their measurement, made studies difficult to compare. It would have been helpful 
to compare effect sizes across different methodologies to determine whether this 
influenced findings. This was not possible however as only half the studies contained 
enough information to calculate effect sizes. Only one study evaluated the effect of 
titrating task demand, therefore it was not possible to investigate the effect of this on 
outcome. Whilst this type of research has several inherent limitations, based on the 
findings of this review a number of recommendations for future studies are made.  
Recommendations for Future Studies 
Study design. 
1.  Methodological rigour could be increased by stating how sample size was 
determined. Sample size should be based on power calculations. 
2.  Study design should take account of potential confounders; in particular age, 
education and fatigue. The possible effects of fatigue on performance on experimental   17 
trials can be controlled for by i) comparing participants performance on a timed walk 
before and after the experimental trials ii) counterbalancing experimental trials and iii) 
participants completing a fatigue questionnaire that measures general fatigue levels. 
3.  Studies comparing the effects of fixed and titrated demand cognitive tasks are 
needed, in order to control for individual differences in single task performance. 
Measurement issues. 
1.  Walking a fixed time rather than distance is preferable as it ensures all participants 
are exposed to dual-tasking for the same duration. Though this cannot take account of the 
fact that walking may be more physically effortful for patient groups than for controls, it 
ensures that both groups are dual-tasking for the same duration.   
2.  It is not clear if a 30 second walk is long enough to elicit a dual-task effect or 
indeed the optimum length of time required. Haggard and colleagues (2000) found that the 
dual-task effect was most apparent in the last 30 seconds of a 60 second walk. This 
suggests that at least a 60 second walk should be considered.  
3.  It is important that the cognitive task is attentionally demanding and without floor 
or ceiling effects. Tasks such as verbal fluency, digit span and serial sevens are more likely 
to be attentionally demanding than listening tasks or tasks involving answering 
autobiographical questions. Verbal fluency is a task that is self-titrated, rather than having 
fixed and titrated demand versions. 
4.  Performance on the cognitive task should be measured. Measurement could include 
number of responses or percent of correct responses.  
5.  Performance on both motor and cognitive tasks should be compared in single and 
dual-task conditions. 
6.  Means and standard deviations for difference scores, i.e. the mean difference 
between single and dual-task performance and the standard deviation of the difference,  
should be reported, to allow calculation of effect sizes.   18 
7.  Combined decrement scores should be calculated and reported as in the dual-task 
some participants will have greater decrement on cognitive performance and others will 
have greater decrement in walking performance. A combined decrement score allows 
comparison of the overall decrement in the dual-task, regardless of whether the effect is on 
cognitive or walking performance. Cocchini and colleagues used Baddeley et al.’s (1997) 
formulae:  
              
    Percentage of change task A =  Single task A-Dual task A     x 100 
                     Single task A 
 
              Combined decrement = 100 -   Percentage of change task A+ Percentage of change task B 
                     2 
 
Questions for Future Research 
Studies to date have generally been limited in their exploration of possible 
mechanisms of and explanations of dual-task effects. There are a number of ways in which 
this future research could address this issue. First, if studies adopted the approach of 
reporting difference scores it should be possible to compare dual-task effects between 
different neurological conditions. This might provide greater information about the 
different mechanisms at work. 
Second, in their review of dual-tasking in Parkinson’s disease Bloem and colleagues  
(2006) identified that patients adopted a ‘posture second’ strategy, in which cognitive 
performance was maintained while motor performance decreased in dual-task conditions. 
Improved measurement in studies, as outlined above, would allow similar analyses of 
strategies in other patient groups. Better knowledge of the mechanisms of poor dual-task 
performance would lead to the development of improved assessment and rehabilitation 
strategies.   19 
Third, it would be helpful to examine of the relationship between executive function 
and performance under dual-task conditions. Recent studies have begun to examine this. 
Yogev and colleagues (2005) compared performance of Parkinson’s disease patients and 
controls on executive and memory tasks. Patients performed worse on the executive tasks 
than controls and performance on the executive tasks correlated with dual-task 
performance. The executive tests used focus primarily on set shifting and response 
inhibition. This suggests that a divided attention impairment results in poor walking and 
talking performance, rather than poor performance simply being a result of increased task 
demand in dual-task conditions. Yogev-Seligman and colleagues (2008) discuss the 
possible impact of executive functions; including volition self-awareness, planning, 
response inhibition, response monitoring and divided attention; on gait and review findings 
of studies examining executive function and gait. They conclude that assessment of 
executive function and dual-task walking should become a part of the routine examination 
among neurological patients in order to more fully evaluate gait abnormalities and fall risk. 
Sheridan and Hausdorff (2007) review the role of executive function in gait and its 
possible relation to falls, in Alzheimer’s disease. They suggest several possible 
mechanisms whereby impaired cognition influences gait in Alzheimer’s disease; 
disintegration of higher cortical sensory function leads to breakdown of automaticity of 
walking, poor control of timing in the cerebellum leads to variability of stepping and 
subsequent gait unsteadiness, and impairment of working memory which is necessary for 
sequential ordering of movement leads to instability of an automatic walking program. 
They suggest a treatment approach that specifically targets executive function in order to 
reduce the rate of falls.  Future studies could routinely include standard measures of 
executive function and attempt to use them to explain mechanisms of dual-task 
performance.  
 
   20 
Conclusions 
The findings suggest that a concurrent cognitive task has a disproportionate effect on 
walking in Alzheimer’s disease, Parkinson’s disease, brain injury and stroke. It was not 
possible to determine the effects of titrating task demand. Effect size could only be 
calculated for half the studies, with a large median effect size. This meant that meta-
analytic review was not possible. Analysis of study quality identified a number of 
methodological issues, which future studies could address.  
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Table 1  
 
 
 
Quality Criteria Protocol 
 
CRITERION 
PARTICIPANTS 
 Cases are clearly defined and differentiated from non-cases 
It is clearly established that controls are non-cases 
Exclusion criteria are sufficiently described 
The same exclusion criteria are used for cases and controls 
The disease state of cases is reliably assessed and validated 
Cases & controls are taken from similar populations  
The % of cases and controls that participated are described 
Participants and non-participants are compared 
CONFOUNDING FACTORS 
Potential confounders are identified and taken into account in design and analyses 
STUDY DESIGN 
Measures are appropriate e.g. have sufficient reliability , no floor or ceiling effects 
STUDY DESCRIPTION 
Settings and location of data collection described  
How sample size determined is outlined & power is sufficient 
Objectives and hypotheses outlined 
Outcome measures described 
Precise details of intervention and how and when administered described 
RESULTS 
Demographic and clinical characteristics of each group described & compared 
Number of participants in each analyses described  
Appropriate statistical analyses performed  
Multiplicity of analyses is addressed  
TOTAL QUALITY SCORE 
_________________________________________________________________________ 
 
Note. For each criterion a score of 2 (yes), 1 (partial) or 0 (no or not reported) was awarded             
Table 2 
 
 
Summary and Quality Ratings of Studies Included in Review 
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
ALZHEIMER’S  DISEASE             
Camicioli 1997 
 
25/38 
 
 
0.74 
0.83 ns 
0.54 ns 
0.46 ns 
AD            n=15 
Old old      n= 20 
Young old n= 23 
30 foot (9.14 
metres) walk 
Reciting names  Walking 
- Time taken 
- No. of steps 
Cognitive task not measured 
-Increased walking time in dual 
task 
-No difference in steps taken 
Cocchini 2004a 
 
25/38 
 
0.84  AD            n= 15 
Controls    n= 15 
30 second walk  Association fluency   Walking 
- Distance walked 
Cognitive task 
- No. of words 
-No differences in distance or no. 
of words 
-Greater combined dual-task 
decrement scores in AD 
Cocchini 2004b 
 
25/38 
 
0.55ns  AD            n= 15 
Controls    n= 15 
30 second walk  Titrated digit span  Walking 
- Distance walked 
Cognitive task 
- % digit span correct 
-Reduced distance in dual task 
 -No difference in decrement 
scores 
Petterson 2005 
 
23/38 
 
1.2 
0.7 
Controls    n= 33 
MCI          n= 59 
AD            n= 22 
OD            n= 26 
10 metre walk  TUG task. 
Cognitive task not 
described 
Walking 
- Time taken 
Cognitive task not measured 
-Both AD & OD greater reduction 
in speed in dual task 
2
8
  
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
Petterson 2007 
 
27/38 
 
1.2  Controls   n= 25 
MCI         n=6 
AD           n= 6 
10 metre walk  Reciting names  Walking 
- Time taken 
Cognitive task not measured 
-AD greater reduction in speed in 
dual task 
 
BRAIN   INJURY             
Cantena 2007 
 
28/38 
 
  Concussed n= 14 
Controls     n= 14 
8 metre walk  Mini-mental tasks; 
DLROW, 
continuous 
subtraction or 
months backwards 
Walking 
- gait velocity 
- stride time 
- stride length 
- step width 
Cognitive task  
- Measured but not indicated 
how 
- No decrement differences found  
in walking or cognitive tasks 
2
9
  
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
Haggard 2000 
 
20/38    Patients       n=50 
(mixture of 
traumatic brain 
injury and stroke) 
Controls      n=10 
60 second walk  1) Category fluency 
and 
2) Mental 
arithmetic and 
3) VPA monitoring 
and 
4) Visuospatial task 
Walking 
- No. of strides 
- Median duration 
- Variability in stride 
duration 
Cognitive tasks 
- No. of errors 
- Dual task decrement in stride 
duration for all cognitive tasks, no 
difference in gait variability 
- Increased errors in word 
generation, mental arithmetic, 
VPA monitoring but not 
visuospatial tasks in dual task 
conditions 
- Decrement in dual task word 
generation confined to last 30s 
- Dual task performance correlated 
with ADL. Standard gait measures 
did not correlate with ADL 
Parker 2005 
 
22/38    Concussed  n= 10 
Controls     n= 10 
10 metre walk  Serial sevens or 
DLROW or 
months backwards 
Walking 
- gait velocity 
- step width 
- stride length & time 
- Whole body CoM motion 
& velocity 
Cognitive task not measured 
- Increased medio-lateral CoM 
sway while walking in dual-task 
condition in patients but not 
controls 
3
0
  
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
Vallee 2006 
 
25/38    TBI             n= 9 
Controls      n= 9 
11 metre walk  Stroop  Walking 
- speed 
- stride length 
- foot clearance margin 
Cognitive task 
- reading time 
- Stride length decreased in dual 
task, no difference in speed 
decrement 
- No difference in reading time 
decrement 
PARKINSON’S  DISEASE             
Camicioli 1998 
 
22/38 
 
1.2 
0.8 
PD-NF       n=9 
PD-F          n=10 
Controls     n=19 
30 foot (9.14 
metres) walk 
Reciting names  Walking 
- Time taken 
- No. of steps 
Cognitive task not measured 
-PD-F group increased number of 
steps, but not time during dual 
tasking 
Campbell 2003 
 
23/38    PD              n= 9 
Controls     n= 10 
6 metre walk  1) Repeating a 
sentence (low 
cognitive demand)  
2) Reverse days of 
week (high 
cognitive demand) 
Walking 
- time taken 
- no. of steps 
Cognitive task not measured 
- In high (but not low) cognitive 
demand dual task increased time 
and steps  
3
1
  
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
Galletly 2005 
 
21/38 
 
0.6  PD             n= 16 
Control      n=16 
10 metre walk  1) backwards 
counting in threes  
2) verbal fluency 
Walking 
- velocity 
- stride length 
- cadence 
Cognitive task 
- Correct response rate 
- Decreased stride length in dual 
task 
- Slower correct response rate in 
dual task 
OShea 2002 
 
30/38 
0.9 
0.9 
0.7 
0.9 
0.9 
0.7 
PD             n= 15 
Controls    n=15 
10 metre walk  Subtracting serial 
3’s 
Walking 
- speed 
- stride length 
- cadence 
- double support duration 
Cognitive task 
- response rate 
- no of errors 
- Greater decrement in stride 
length, speed and cadence in 
dual task conditions, no 
difference in double support 
duration 
- Controls improved response rate 
during dual tasking, PD did not 
- Increased error rate during dual 
tasking compared to controls 
Rochester 2004 
 
29/38    PD                
n=20 
Controls       
n=10 
Distance 
unspecified  
Answering 
autobiographical 
questions 
Walking 
- speed 
- step length 
- step frequency 
Cognitive task not measured 
- Greater decrement in speed & 
step length in dual task 
3
2
  
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
Yogev 2005 
 
28/38    PD               n=30 
Controls      n=28 
2 minute walk  1) listening to text 
(simple task) and 
2) listening to text 
and counting word 
occurrences 
(complex task) and 
3) serial sevens 
Walking 
- velocity 
- stride time and variability 
- swing time and variability 
- speed 
Cognitive task 
- listening comprehension 
- subtraction errors 
- No difference between groups in 
dual-task decrement in speed 
 - Gait variability differentially 
affected in patients in dual-task 
- Decrement in performance on 
serial sevens in dual task 
- Gait variability during dual task 
correlated with tests of executive 
function, gait variability during 
normal walking did not 
STROKE               
Hyndman 2006 
 
21/38 
 
0.5  Stroke        n=36 
Controls     n=24 
5 metre walk  Remembering 7 
item shopping list 
Walking 
- time taken 
- stride length 
- velocity 
Cognitive task 
- no of items recalled 
- Increased walking time in dual 
task 
- Fewer items recalled in dual task 
3
3
  
Reference  Quality 
score 
Effect 
Size 
Participants  Walking task  Cognitive task  Outcome measures  Results in patient group 
compared to control 
Kemper 2006 
 
23/38    Stroke        n=10 
Controls     n=10 
3-5 minute 
walk 
Answering 
autobiographical  
questions 
Walking 
- errors while walking 
- steps per second 
Cognitive task 
- language fluency 
- grammatical complexity 
- language content 
- Decreased time on task in dual 
task, no effect on walking errors 
- Fluency, grammatical complexity 
and content decreased in dual task 
for stroke but not controls 
________________________________________________________________________________________________________________________________________________________________________ 
 
Note. AD= Alzheimer’s disease, MCI= Mild Cognitive Impairment, OD= Other dementia, PD= Parkinson’s disease, PD-F= Parkinson’s disease freezing, PD-NF= Parkinson’s disease no freezing, Reh. 
=Rehabilitation, Phys.=Physical, n.s= not statistically significant in study analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
4
  
Table 3 
 
 
Walking and Cognitive Tasks Employed in Studies  
 
Task  Studies using this task  Number  of  studies that found  a  dual-
task effect in this task 
WALKING TASKS     
30-60 second walk  Cocchini et al. (2004a & b), Haggard et al. (2000)  2/3 
120 second walk  Yogev et al. (2005)  1/1 
3-5 minute walk  Kemper et al. (2006)  1/1 
5 metre walk  Hyndman et al. (2006)  1/1 
6 metre walk  Campbell et al. (2003)  1/1 
8 metre walk  Cantena et al. (2007)  0/1 
9-11 metre walk  Camicioli et al. (1997, 1998), Pettersson et al. (2005, 2007), Parker et al. (2005), 
Vallee et al. (2006),  Galletly et al. (2005), OShea et al. (2002) 
7/7 
Unspecified  Rochester et al. (2004)  1/1 
COGNITIVE TASKS     
Verbal fluency task  Camicioli  et  al.  (1997),  Cocchini  et  al.  (2004a)Pettersson  et  al.  (2005,  2007), 
Haggard et al. (2000), Camicioli et al. (1998), Galletly et al. (2005) 
7/7 
Digit span task  Cocchini et al. (2004) B  1/1 
Subtracting serial numbers, reciting 
days of week backwards, spelling 
Cantena et al. (2007), Haggard et al. (2000), Parker et al. (2005), Campbell et al. 
(2003), Galletly et al. (2005), OShea et al. (2002) 
5/6 
3
5
  
Task  Studies using this task  Number  of  studies that found  a  dual-
task effect in this task 
WORLD backwards 
STROOP  Vallee et al. (2006)  1/1 
Autobiographical questions  Rochester et al.  (2004), Kemper et al. (2006)  2/2 
Repeating sentences  Campbell et al. (2003)  0/1 
Simple listening task  Yogev et al. (2005)  1/1 
Learning seven item shopping list  Hyndman et al. (2006)  1/1 
Verbal monitoring task  Haggard et al. (2000), Yogev et al. (2005)  2/2 
Visuospatial task  Haggard et al. (2000)  1/1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
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Table 4 
 
 
Walking Parameters Used in Included Studies 
 
Walking parameter  Studies using this parameter  Number  of  studies  that  found  a  dual-task 
effect in this parameter 
Time taken  Camicioli et al. (1997), Camicioli et al. (1998), Pettersson et al. (2005), Pettersson et 
al. (2007), Campbell et al. (2003), Hyndman et al. (2006) 
5/6 
Distance walked  Cocchini et al. (2004a & b)  1/2 
Number of steps  Camicioli et al. (1997), Camicioli et al. (1998), Campbell et al. (2003), Rochester et al. 
(2004), Kemper et al. (2006) 
3/5 
Velocity  Cantena et al. (2007), Parker et al. (2005), Vallee et al. (2006), Galletly et al. (2005), 
OShea et al. (2002), Rochester et al. (2004), Yogev et al. (2005) 
2/7 
Stride time  Cantena et al. (2007), Parker et al. (2005)  0/2 
Stride length  Cantena et al. (2007), Parker et al. (2005), Vallee et al. (2006), Galletly et al. (2005), 
OShea et al. (2002), Rochester et al. (2004), Hyndman et al. (2006) 
4/6 
Step width  Cantena et al. (2007), Parker et al. (2005)  0/2 
Stride variability  Yogev et al. (2005)  1/1 
Swing variability  Yogev et al. (2005)  1/1 
Median duration  Haggard et al. (2000)  1/1 
Variability  Haggard et al. (2000)  0/1 
3
7
  
Walking parameter  Studies using this parameter  Number  of  studies  that  found  a  dual-task 
effect in this parameter 
Whole body Centre of Mass 
motion & velocity 
Parker et al. (2005)  1/1 
Foot clearance margin  Vallee et al. (2006)  0/1 
Cadence/Step frequency  Galletly et al. (2005), OShea et al. (2002), Rochester et al. (2004)  1/3 
Double support duration  OShea et al. (2002)  1/1 
Walking errors  Kemper et al. (2006)  0/1 
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Figure Captions 
 
 
Figure 1. Flowchart of article selection process. 
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
Articles identified by electronic 
search and screened for retrieval 
n=28 
Articles identified by hand search of 
reference lists and screened for retrieval 
n=13 
Total articles n=41 
Total excluded articles n=25 
 
Motor task is not walking        n= 9 
Not a dual tasking study     n= 4 
No healthy control group   n= 6 
No cognitive task                    n= 1 
Case report                             n= 1 
 Review paper                         n= 2 
  Data presented in 
previous paper               n= 2 
 
 
Total included articles n=16 
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Abstract 
 
Problems with walking and attention are known to be prevalent in Multiple Sclerosis (MS), 
though no studies have reported how these two difficulties might interact. The study aimed 
to investigate the effects of performing a concurrent cognitive task when walking in MS 
and determine the effects of task demand on dual-task performance. Eighteen MS 
participants and 18 healthy controls took part. Participants completed walking and 
cognitive tasks under single and dual task conditions. MS participants, compared to healthy 
controls, had greater decrements in dual-task performance; including decrements in 
cognitive task performance, walking speed and swing time variability. Dual-task 
decrements were evident in titrated and fixed demand conditions. Dual-task decrements 
were related to fatigue, cognitive functioning and self-reported cognitive errors, but not to 
measures of disease severity or duration. MS participants perform differentially poorly on 
walking and talking dual-tasks compared to healthy controls. This may lead to difficulties 
in everyday life and increase the risk of falls in MS. Clinicians should independently assess 
dual-task walking in MS patients. The role of task demand in dual-tasking decrements 
remains unclear and needs further investigation. Future studies should replicate the current 
findings and develop practical clinical tools to assess walking and talking ability.  
 
Key words: Adult, attention, memory, neuropsychological tests, gait, nervous system 
disorders 
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Introduction 
         Problems with walking and cognition are common in Multiple Sclerosis (MS). 
Cognitive impairment affects about 50% of people with MS (NICE, 2004). One of the 
most frequently impaired cognitive domains is attention (Calabrese, 2006), with 22-25% of 
people with MS reporting attentional problems (Sullivan, et al., 1990 and Arnett, 2003). In 
a recent review of neuropsychological impairment in MS, Calabrese (2006) concluded that 
impairment of attention appears to occur early in the disease and may contribute to 
subsequent dysfunction in memory and abstract reasoning. 
Despite apparently being a common difficulty there are only a few studies 
investigating attention in MS (Calabrese, 2006). McCarthy et al. (2005) investigated 
divided and sustained attention in MS. They reported that MS participants were slower and 
less accurate on both types of attention compared to controls and that divided attention was 
more impaired than sustained attention. D’Esposito et al. (1996) used a dual-task paradigm 
with people with MS, asking participants to perform two cognitive tasks simultaneously in 
the dual-task condition. They found that, compared to healthy controls, MS participants 
had a greater reduction in performance in the dual-task condition compared to the single 
task, suggesting a differential impairment in divided attention.  
Up to 50% of people require assistance walking within 15 years of MS onset 
(Ruddich, 1999). Walking has traditionally been considered automatic or reflex controlled, 
requiring minimal attentional resources (Woollacott & Shumway-Cook, 2002). A recent 
review however suggests that control of walking can be attentionally demanding 
(Woollacott & Shumway-Cook, 2002). In healthy young adults this is detectable only 
when quite complex additional secondary tasks are performed in addition to walking, while 
in healthy older adults performing a secondary task appears to have a more deleterious 
effect. 
Dual-tasking refers to the ability to do two things at once. Recent studies have 
investigated the effects of a particular type of dual-tasking in  neurological conditions;   45 
performing concurrent cognitive tasks while walking.  Studies of people with Alzheimer’s 
(e.g. Cocchini et al., 2004) and Parkinson’s disease (e.g. Yogev et al., 2005) have 
suggested that speed and accuracy of walking is affected by simultaneously performing a 
cognitive task. The research suggests that in these neurological conditions performing 
concurrent tasks has a disproportionate effect on walking, compared to healthy controls 
(Hamilton et al., chapter one this volume; Woollacott & Shumway-Cook, 2002). As well 
as having implications for everyday life, where we are frequently required to do two things 
at once, dual-tasking difficulties may help explain the high risk of falls (Cocchini et al., 
2004) and may have implications for the assessment and rehabilitation of walking 
(Haggard et al., 2000) in several neurological conditions. A recent study using randomised 
control trial methodology reported that a cognitive-motor training programme, involving 
walking with simultaneous cognitive tasks of gradually increasing demand, may lead to 
improvements in walking and talking in people with acquired brain injury (Evans et al., 
submitted).  
There are three possible explanations for the development of a dual-tasking deficit 
(Hamilton et al., chapter one this volume). One is that basic deficits in motor functioning 
mean that motor tasks require more conscious attention for successful performance. 
Mulder and colleagues, for example, postulate that when the motor system is damaged 
control of movement is primarily directly cognitive (Mulder et al., 2002) and under a ‘slow 
mode’ of control.  Walking becomes an attention demanding task. The limited capacity 
working memory system is therefore overloaded in the dual-task situation. Another 
possibility is that in neurological conditions working memory capacity is reduced, so that 
is overloaded by previously normal loads of motor and cognitive content. A third 
possibility is that rather than basic working memory capacity being the problem, there is a 
deficit in the attention control system that allocates attention between concurrent demands 
(Logie et al., 2004).  Baddeley and Hitch’s working memory model suggests that a central 
executive is responsible for dividing attention between concurrent tasks (Baddeley &   46 
Hitch, 1974). From this model a difficulty performing two concurrent tasks is seen as due 
to a deficit in the ability to allocate attentional resources to competing demands, rather than 
due to insufficient attentional capacity. Deficits in divided attention are well documented 
in a variety of neurological conditions.  
It has been argued (e.g. Cocchini et al., 2004 and Logie et al., 2004) that in studying 
dual-tasking it is important to control for this task demand effect when comparing a patient 
group with a healthy control group. In order to determine whether dual-tasking difficulties 
are specifically caused by a divided attention/dual-tasking process impairment they suggest 
that it is necessary to titrate tasks according to performance under single task conditions. 
Logie et al. (2004) for example investigated the effects of manipulating task demand on 
performing two simultaneous cognitive tasks in patients with Alzheimer’s disease and 
healthy controls. It was reported that there was a greater dual-task decrement in patients 
with AD, compared to healthy controls, independent of overall task demand, suggesting a 
divided attention impairment, rather than a capacity issue. Titrating dual-task demand to 
single task performance therefore has the advantage of making it clearer whether a divided 
attention deficit is responsible for difficulties under dual-tasking conditions, though may be 
less clinically relevant to the extent that everyday conditions are not titrated to individual 
performance levels. 
Difficulties both with walking and attention are known to be prevalent in people with 
MS, though no studies have investigated how these two difficulties might interact as in 
other neurological conditions. The present study seeks to investigate the effects of 
performing a simultaneous cognitive task when walking in MS. In order to determine 
whether dual-tasking difficulties are specifically caused by a divided attention/dual-tasking 
process impairment both titrated and fixed demand tasks will be used. 
The aims of this study were; to investigate whether cognitive-motor dual-tasking is 
impaired in MS, relative to healthy controls; to investigate whether any cognitive-motor 
dual-tasking impairment in  MS is due to increased task demand or a divided attention   47 
deficit; and to identify any association between self-reported attentional difficulties, self-
reported fatigue and dual-task performance.  
It was expected that MS participants would perform differentially poorly on dual-
tasks compared to controls. Specifically, it was hypothesised that performance on measures 
of walking and an additional cognitive task would be disproportionately impaired in dual-
task conditions compared to single-task conditions (in MS participants compared to 
controls). 
 
 
Method 
Ethical Approval 
The study was granted ethical approval by the local NHS Research Ethics 
Committee.  
Participants 
Power calculations indicated that a sample size of n= 20-26 per group was needed 
(see Appendix C1, page 111). Participants were people with MS and healthy controls. MS 
participants were recruited from MS clinics by two research nurses and a consultant 
neurologist specialising in MS. Controls were recruited via MS participants and via 
recruitment posters placed throughout the hospital in which the study was being conducted.   
Inclusion criteria for MS participants were; a diagnosis of relapsing-remitting MS 
and an Expanded Disability Status Scale (EDSS) score (Kurtzke, 1983) up to 5.5. 
Relapsing-remitting MS refers to clearly defined disease relapses with either full recovery 
or with residual deficit upon recovery; periods between relapses are characterised by a lack 
of disease progression (NICE, 2004). Diagnosis of MS was made by a consultant 
neurologist specialising in MS using the Poser (Poser et al., 1983) and McDonald 
(McDonald et al., 2001) criteria i.e. at least two clinical attacks and abnormal MRI 
consistent with MS, either with or without abnormal CSF consistent with MS. An EDSS   48 
score up to 5.5 indicates minimal or moderate impairment in up to four functional systems 
and an ability to walk at least 100 meters unaided. EDSS scores were assessed by a 
consultant neurologist. Healthy controls were matched for age. Exclusion criteria for both 
MS participants and healthy controls were; major psychiatric disorder, history of brain 
injury or neurological disease (other than MS) and a history of falls in the past month. 
Healthy controls with a history of any disorder affecting walking were also excluded.  
Design 
A cross sectional design was used comparing the performance MS and control 
participants under single and dual task conditions.  
Materials  
Baseline assessment 
Pre-morbid intellectual functioning was assessed using the Weschler Test of Adult 
Reading (WTAR) (Weschler, 2001). Reliability and validity have been reported as good; 
with internal consistency coefficients of 0.87 to 0.95, test-retest correlation coefficients of 
0.90 and correlation coefficients of 0.73 with the Weschler Adult Intelligence Test Full 
Scale IQ score (Spreen et al., 2003).  
General cognition was assessed using the Addenbrooke’s Cognitive Examination-
Revised (ACE-R), a brief cognitive test designed to screen for dementia. It has not been 
validated with MS but was used in this study to describe basic cognitive function of 
patients and controls. In the general population sensitivity of 0.94 and specificity of 0.89 
have been reported at a cut-off of 88/100 (Hodges, 2007).  
Cortical vision was screened using the Cortical Vision Screening Test (CVST) 
(James et al., 2001). This test includes ten sub-tests each designed to evaluate a different 
aspect of early visual processing and identifies visual problems with a cortical cause.   
Anxiety and depression were screened using the Hospital Anxiety and Depression 
Scale (HADS) (Zigmund and Snaith, 1983). The HADS is a self-report instrument 
designed for use with non-psychiatric hospital patients. The reliability and validity of the   49 
HADS is described as good to very good with internal consistency coefficients of 0.8, 
concurrent validity of 0.6 to 0.8 and both sensitivity and specificity of 0.8 (Bjelland et al., 
2002). 
Fatigue was assessed using the Modified Fatigue Impact Scale (MFIS) (Multiple 
Sclerosis Council for Clinical Practice Guidelines, 1998). The MFIS is a 20-item self-
report instrument. It is the recommended measure for fatigue in MS (Multiple Sclerosis 
Council for Clinical Practice Guidelines, 1998) with good reliability (e.g. internal 
consistency coefficients 0.92, intra-class correlation coefficient 0.91) and validity 
(convergent validity coefficient 0.67) reported in MS patients (Kos et al., 2005). 
Self-rated attention was measured using the Cognitive Failures Questionnaire (CFQ) 
(Broadbent, 1982). Good reliability, with internal consistency coefficients of 0.76 to 0.86, 
and construct validity have been reported (Wallace et al., 2002). 
Disease severity of MS was assessed using Kurtzke’s EDSS (Kurtzke, 1983).  
The following demographic information was recorded; age, gender, history of mental 
health problems, medical history, disease type (MS participants) and years of illness (MS 
participants). 
An individual digit span assessment (see Appendix C2) was completed using 
Cocchini et al.’s method (2004). Participants listened to a string of digits and repeated 
them back (e.g. 3-2-5). Cocchini et al. presented the digits at the rate of two per second, in 
the current study however digits were presented at the rate of one per second.Three trials 
were given at each sequence length. If two out of three trials at a given length were correct 
the participant was deemed to have passed that sequence length and the length was 
increased by one digit. Each participant’s digit span was determined as the last sequence 
length at which two out of three trials were correct. 
Gait assessment 
The GAITRite System was used to measure walking parameters. The GAITRite 
system is a flexible electronic walkway providing automated measurement of the spatial   50 
and temporal parameters of gait using a carpet embedded with sensors which detect 
footfalls.  It has been shown to give valid and reliable data (van Uden & Besser, 2004). 
The carpet is 457cm long with an active area of 366cm and a sampling rate of 32.3-
38.4Hz.  The GAITRite was placed so that it formed part of a circuit of approximately 18 
metres.  
During all walking trials participants walked unaided around the circuit continuously 
for 90 seconds until told to stop. They were instructed to walk at their preferred speed. 
Participants performed between three and six repetitions of the circuit during each trial. 
Walking speed, step length, step frequency, step time, swing time and double limb support 
time variability were automatically calculated by computer software designed for 
GAITRite and recorded on disc for later analysis. Distance walked during each trial was 
measured manually by the researcher.  
Cognitive tasks   
There were two cognitive tasks; a fixed and a titrated demand task. During each task 
participants listened to sequences of digits, played aloud on a CD player, and were required 
to repeat each sequence in order. During the fixed demand task all participants were 
presented with sequences that were seven digits in length, since this is the average digit 
span in adults (Miller, 1956). During the titrated demand task participants were presented 
with sequences at their own digit span length; as assessed in the baseline digit span 
assessment. Participant responses were recorded by a pocket sized digital voice recorder 
with portable microphone worn by the participant. The percentage of digit sequences 
correctly recalled was later calculated by the researcher. Development of the CD version of 
cognitive tasks is described in Appendix C3.  
Procedure 
All participants provided written informed consent. Participants first completed the 
baseline assessment measures as described. Participants then completed walking and 
cognitive tasks under both single and dual task conditions. In total each participant   51 
completed five trials; walking alone, fixed digit task alone, titrated digit task alone, 
walking with fixed digit task and walking with titrated digit task. Each trial lasted 90 
seconds. Trials were counter-balanced to ameliorate order effects. To control for fatigue 
effects, counter-balancing was blocked to ensure two walking tasks did not occur together. 
Immediately before and after the protocol, participants completed three repetitions of a 
timed 10metre walk to determine any impact of fatigue on walking performance.  
Data Analysis 
Descriptive statistics are reported as mean + standard deviation or, where indicated, 
medians (95% confidence intervals). Student’s t, Mann Whitney U and chi-square tests 
were used as appropriate to compare MS and control participants on demographic and 
baseline clinical characteristics. Decrement scores, i.e. percentage change from single to 
titrated and fixed demand dual-task performance, were calculated for each outcome 
measure. Combined decrement scores, i.e. a single score for the overall combined change 
in cognitive task and walking task performance under titrated and fixed demand dual-task 
conditions, were calculated for cognitive task and each walking outcome measure. 
Decrement and combined decrement scores for MS and control participants were 
compared on each outcome measure using Student’s t and Mann Whitney U tests as 
appropraite. Since specific predictions were made regarding findings and effect sizes (r) 
are reported Bonferroni corrections were not applied, due to the risk of Type II errors.  
The relation between education, pre-morbid ability, general cognition and self-
reported depression, anxiety, cognitive errors, fatigue and dual-task decrement scores was 
investigated using Pearson correlation coefficients (r). Association between measures of 
disease severity (EDSS score, years since diagnosis) in the MS group only and dual-task 
decrement scores was also investigated using Pearson correlation coefficients (r). Logistic 
regression was used to explore the relative ability of dual-task decrement and measures 
which correlated with dual-task decrement to predict whether a participant was from the 
MS or control group.   52 
Results 
Descriptive Characteristics 
Eighteen people with MS and 18 healthy controls took part. The basic demographic 
and clinical details of each group are outlined in Table 1. MS participants were in 
remission and did not use walking aids. Of the 18 healthy controls, five were recruited via 
MS participants and 13 were recruited using posters. Both groups were similar with respect 
to age and gender. There were statistically significant differences in pre-morbid ability and 
education, with controls on average having 1.76 years more education. MS participants 
performed more poorly on the ACE-R; five MS participants scored in the possible 
dementia range compared to none of the controls. MS participants reported greater levels 
of fatigue, everyday cognitive errors and (non-clinically significant) anxiety and 
depression. None of the controls reported falling in the past 6 months, while MS 
participants reported an average of 0.8 falls. There was no difference between MS and 
control participants in assessed digit span with an average digit span of 6.39 (range 4-9) in 
MS participants and 6.5 (range 5-9) in controls. When time to walk 30 metres after 
experimental trials were completed was subtracted from time to walk 30 metres prior to 
experimental trials there was no difference between MS and control participants.   
[INSERT TABLE 1 HERE] 
The data were analysed to determine percentage correct in the digit task, walking 
speed, step frequency, step time, step length, swing time variability and double support 
time variability for each task alone and in titrated and fixed demand dual-task conditions. 
Step frequency, step time and step length were highly correlated with walking speed (r= 
0.958, -0.929, -0.925 respectively, p<0.001) and were therefore excluded from further 
analyses. The performance of MS and control participants for each task alone and in 
titrated and fixed demand dual-task conditions is presented in Table 2 and Figure 1.  
[INSERT TABLE 2 HERE] 
[INSERT FIGURE 1 HERE]   53 
Comparison of Single and Dual-Task Performance for Titrated and Fixed Task Demand 
Percentage change (decrement) from single to dual task performance was calculated 
using Baddeley et al.’s (1997) formula (as cited in Cocchini et al., 2004):  
 
Percentage of change task A =     Single task A – Dual task A     x 100 
Single task A 
 
The percentage changes, or decrements,  in digit task, walking speed, swing time 
variability and double support time variability from single to dual task for titrated and fixed 
task demand are outlined in Table 3 and Figures 2 and 3. Since neither pre-morbid ability 
nor education correlated with primary outcome measures (see Table 5) in dual-task 
conditions they were not included as covariates in analyses.  
[INSERT TABLE 3 HERE] 
Digit task performance 
There was a statistically significant difference between MS and control participants 
in digit task performance decrement in fixed demand (t (df 34) = -2.219, p = 0.033 two-
tailed, r = 0.36), but not titrated demand (t (df 34) = -1.564, p = 0.127 two-tailed, r = 0.26), 
dual-tasks. The percentage of digit span tasks performed correctly by MS participants 
reduced by 14% and 17% in titrated and fixed demand dual-tasks respectively, compared 
to 3% and 0% for controls.  The small-medium effect size (r = 0.26) in the titrated demand 
dual-task suggests the study may have lacked power to detect this effect. 
Walking speed 
There were statistically significant differences between the groups for walking speed 
decrement in both titrated (t (df 25.913) = -3.959, p = 0.001 two-tailed, r = 0.61) and fixed 
(t (df 34) = -4.467, p < 0.001 two-tailed, r= 0.61) demand dual-tasks. This was a large 
effect size with average walking speed decreasing by 9% and 11% in titrated and fixed 
demand dual-tasks respectively for MS participants, compared to 2% and 2% for controls.    54 
Swing time variability and double support time variability
‡ 
Change in swing time variability between single and dual-task conditions was 
statistically significantly different for MS participants compared to controls in the fixed 
demand dual-task (U (N 36) = 96, p = 0.037 two-tailed, r = 0.35). MS participants 
increased swing time variability by an average of 19% in fixed demand dual-tasks, 
compared to a 7% decrease for controls. In the titrated demand dual-task there was a trend 
towards a significant difference between the groups, (U (N=36) = 104, p = 0.068, r = 0.31), 
the medium effect size indicating that failure to reach significance is a result of a power 
issue. MS participants increased swing time variability by 30% in titrated demand dual-
tasks, compared to 5% for controls. There were no statistically significant differences 
between MS and control participants for double support time variability in either fixed (U 
(N=36) = 124, p = 0.239, r = 0.200) or titrated (U (N=36) = 141, p = 0.521, r = 0.11) 
demand dual-tasks.  
[INSERT FIGURES 2 & 3 HERE] 
Combined Decrement from Single to Dual-Task Performance for Fixed and Titrated Task 
Demand 
A single score for the overall combined change in cognitive task and walking task 
performance under dual-task conditions was calculated using the following formula 
(Baddeley et al., 1997):  
 
Combined decrement score =   Percentage change task A + Percentage change task B 
               2 
A combined decrement score was calculated for cognitive task and each of walking 
speed, swing time variability and double support time variability. Combined decrement 
scores for MS and control participants in both titrated and fixed demand dual-tasks are 
outlined in Table 4.  
                                                 
‡ See Appendix C4, page 123, for definitions of swing time and double support time and brief overview of 
gait cycle.   55 
[INSERT TABLE 4 HERE] 
Cognition and walking speed 
There were statistically significant differences between MS and control participants 
for combined cognition and walking speed decrement in both titrated (t (df 34)  = -2.418, p 
=  0.021 two-tailed, r = 0.38) and fixed  (t (df 34) = -3.274, p = 0.002 two-tailed, r = 0.49) 
demand dual-tasks. On average MS participants overall performance decreased by 12% in 
the titrated demand dual-task and 14% in the fixed demand dual-task, compared to 2% and 
1% respectively for controls.   
Cognition and swing time variability 
Combined cognition and swing time variability decrement was statistically 
significantly different between MS and control participants in both titrated (U (N=36) = 
98, p = 0.044 two-tailed, r = 0.34) and fixed demand (U (N=36) = 81, p = 0.010, r = 0.43) 
dual-tasks. Overall performance by MS participants decreased by 23% in the titrated 
demand dual-task and 20% in the fixed demand dual-task, compared to a 3% decrease and 
9% improvement respectively for controls.  
Cognition and double support time variability 
There was a statistically significant difference between MS and control participants 
for combined cognition and double support time variability decrement in the fixed demand 
dual-task (U (N=36) = 100, p = 0.051, r = 0.330), with performance of the MS group 
reducing by 20% compared to 1% for controls. There was no statistically significant 
difference between the groups in the titrated demand dual-task (U (N=36) = 118, p = 
0.171, r = 0.23), the overall performance of the MS group decreased by 16% compared to 
3% in controls. 
Exploratory Analysis of Possible Factors Affecting Dual-Task Differences in MS and 
control Participants  
Exploratory correlational analysis was conducted to determine if pooled MS and 
control participants’ differences in dual-task decrement scores could be explained by other   56 
factors. The difference between each participant’s assessed digit span and the fixed 
demand digit span was calculated (e.g. the participant’s assessed digit span might be 5 
while fixed digit span is 7 resulting in a difference of -2). There was no association 
between difference between assessed and fixed digit span and either cognitive task 
decrement for titrated (r= -0.126, p = 0.464) and fixed (r = 0.091, p =0.595) demand dual-
tasks or walking speed decrement for titrated (r = -0.090, p = 0.607) and fixed (r = 0.051, p 
= 0.769) demand dual-tasks. There was a large effect size for the difference in time taken 
to walk 30 metres before and after experimental trials and dual-task decrement in walking 
speed in both titrated (r  = -0.540, p = 0.001) and fixed (r = -0.508, p = 0.002)  demand 
dual-tasks.   
The relation between education, pre-morbid ability, general cognition and self-
reported depression, anxiety, overall cognitive errors, cognitive errors as reported on CFQ 
Question 9, fatigue and dual-task decrements was explored in pooled MS and control 
participants. CFQ Question 9 was selected for this analysis as this CFQ question most 
closely relates to dual-tasking ability; ‘Do you fail to hear people speaking to you when 
you are doing something else?’ The results are outlined in Table 5. Self-reported fatigue 
and performance on a cognitive screening test (ACE-R) were related to decrement in 
walking speed in fixed demand dual-tasks (r = 0.387, -0.385, p = 0.020, 0.020 
respectively). Decrement in walking speed in the titrated demand dual-task was related to 
cognitive errors as reported on CFQ Question 9, while in fixed demand dual-task 
conditions this association approached statistical significance (r = 0.332, 0.320, p = 0.048, 
0.057 respectively).  Further analysis, shown in Table 6, indicated there was no association 
between measures of disease severity in the MS group (EDSS score or years since 
diagnosis) and dual-task decrements.  
[INSERT TABLES 5 & 6 HERE] 
Logistic regression was used to explore the relative ability of self-reported fatigue, 
performance on a cognitive screening test (ACE-R), cognitive errors (CFQ Question 9),   57 
difference in time taken to walk 30 metres before and after experimental trials and 
decrement in walking speed under fixed demand dual-task conditions to predict whether a 
participant was from the MS group or control group. Independent variables were centred to 
prevent multi-collinearity. Interactions of independent variables were also included in the 
model. Using the forward conditional entry method a significant model emerged (X
2 (df 1) 
= 9.982, p = 0.002). The results are shown in Tables 6 and 7. Performance on the ACE-R, 
CFQ Question 9 and difference in time taken to walk 30 metres before and after 
experimental trials did not enter the model as they did not increase the predictive ability of 
the model. The odds of being from the MS group increased by 1.3 for every 1% change in 
walking speed from single to dual task and by 1.1 for every 1 point increase in MFIS score. 
The overall predictive ability of the model was 73% (Nagelkerke R
2 = 0.728).  
[INSERT TABLES 7 & 8 HERE] 
 
 
Discussion 
Consistent with hypotheses, the main findings were that MS participants, compared 
to healthy controls, had greater decrements in dual-task performance; including decrements 
in digit task performance, walking speed and swing time variability in fixed demand dual-
tasks and in walking speed in titrated demand dual-tasks. The study may have lacked 
power to detect similar differences with smaller effect sizes in titrated demand dual-tasks.  
Differences between MS and control participants in dual-tasks remained when cognitive 
task decrements and decrements on gait measures were combined. Effects sizes were 
medium to large where statistically significant differences were found. 
Fatigue (both self-reported fatigue and physical fatigue from experimental trials) and 
performance on a cognitive screening measure (ACE-R) showed significant relationships 
with dual-task decrement in walking speed during fixed demand conditions. Score on CFQ 
Question 9 showed a significant relationship with dual-task decrement in walking speed   58 
during titrated demand conditions and approached statistical significance in the fixed 
demand dual-task condition. There were no significant relationships between dual-task 
decrement in MS participants and measures of disease severity.  
The Effect of Dual-Tasking in MS  
The findings are consistent with those of D’Esposito et al. (1996), who reported 
differential dual-task decrements in MS participants, compared to controls, when 
performing two cognitive tasks simultaneously. There are several possible explanations for 
the current findings including; reduced working memory capacity, task demand, use of 
different strategies, confounding factors and a divided attention deficit. 
A titrated demand condition was designed in case MS participants had lower assessed 
digit spans than control participants; in this event a fixed demand task would have put MS 
participants at a disadvantage. This was not the case however, there being no difference in 
assessed digit span between groups, suggesting that differential dual-task decrements in 
MS participants are not due to reduced working memory capacity. Thus the fixed demand 
condition simply represents a small increase in demand for both groups.  
In some ways the finding of differential dual-task effects in MS under both demand 
conditions differs from that of Cocchini et al. (2004) who found that dual-task differences 
between people with Alzheimer’s disease and healthy controls disappeared when task 
demand was titrated. The present study differs from Cocchini et al. in three important ways 
however. First, the present study presented the digits at the rate of one per second, which is 
less challenging than the rate of two per second that Cocchini et al. presented them at. 
Second, Cocchini et al. did not include digit span as the cognitive task in both demand 
conditions. Instead their titrated demand condition used the digit span task similar to the 
present study, but their fixed demand task used verbal fluency, a self-titrated task, as the 
cognitive task. Third, the dual-task difference between Alzheimer’s participants and 
healthy controls, reported by Cocchini et al., in the fixed demand condition was quite small   59 
and only evidenced when a combined decrement score was used, not with individual 
decrement scores.  
The results of the present study are more consistent with those of Logie et al. (2004) 
and D’Esposito et al. (1996), suggesting that task demand is not a prime determinant of 
dual-task performance. Logie et al. (2004) reported that manipulating task demand did not 
ameliorate greater dual-task decrements in Alzheimer’s patients, compared to healthy 
controls, suggesting a divided attention deficit rather than an overall capacity issue. 
D’Esposito et al. (1996) did not directly manipulate task demand but reported no difference 
in dual-task decrement between easy and difficult conditions. In the present study however 
the role of task demand remains unclear, as there was no difference in assessed digit span 
between patients and controls.  If, as Mulder et al. (2002) suggest, walking becomes 
attention demanding in MS then the patient group use some of their limited working 
memory capacity for walking, while the control group do not. Therefore, in dual-tasking 
conditions working memory capacity is overloaded in MS participants but not in controls. 
In order to test this it would be necessary to manipulate task demand and investigate dual-
tasking performance when task demand was at assessed level, below assessed level and 
above assessed level. If dual-tasking deficits were not a result of capacity issues one would 
expect to find that differential dual-tasking decrements remained across all demand 
conditions. The lack of association between assessed and fixed digit span difference and 
dual-task decrement scores in this study suggests that differential dual-task decrements in 
MS participants are not simply due to task demand.  
The use of decrement and combined decrement scores allows comparison of MS and 
control dual-task strategies; for example control participants might have prioritised the 
walking task at the expense of the cognitive task while the patient group may have done 
the opposite as, has been reported in Parkinson’s disease (Bloem et al., 2001). The fact that 
differences between MS and control participants remained when decrements in the   60 
cognitive task were combined with decrements on gait measures suggests that differential 
dual-task decrements in MS participants are not due to different prioritisation of tasks.  
MS and control participants differed with respect to several baseline characteristics. 
Of these, fatigue (both self-reported fatigue and physical fatigue from experimental trials) 
and general cognitive functioning were associated with dual-task decrements, suggesting 
that the other characteristics were not confounding dual-task decrement differences in MS 
and control participants.  Fatigue (both self-reported fatigue and physical fatigue from 
experimental trials), CFQ Question 9 score, general cognitive functioning and dual-task 
decrement score were entered into a model to predict MS or control group membership. 
Self-reported fatigue and dual-task decrement score were included in the final model, 
suggesting that these separately contributed to MS or control group membership. This 
suggests that neither physical fatigue from experimental trials, CFQ Question 9 score nor 
general cognitive functioning alone can predict dual-task decrement. This is consistent 
with the findings of D’Esposito et al. (1996) who reported no association between dual-
task decrement and mood or fatigue for MS or control participants. 
The lack of association between measures of disease severity and duration and dual-
task decrement also rule this out as an explanatory factor. D’Esposito et al. (1996) also 
reported no association between disease duration or EDSS score and dual-task decrement. 
The results suggest that MS participants have a differential dual-task impairment; 
which can be partially explained by fatigue and general cognitive functioning but which is 
not due to reduced working memory capacity or use of different strategies. The role of task 
demand remains unclear, for reasons outlined, making it difficult to determine whether the 
dual-task impairment is due to a divided attention deficit or capacity issues. This may be 
less clinically important in that task demands in everyday life are not titrated to individual 
performance levels.  
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Everyday and Clinical Implications 
The findings suggest that people with MS will have everyday difficulties walking and 
talking, with performance on both decreasing when the two tasks are attempted at once. 
This has implications for everyday life where we are frequently required to walk while 
attending to cognitive tasks simultaneously; such as having a conversation while walking, 
crossing a busy road, and navigating a supermarket. Decrease in walking speed may not in 
itself cause undue difficulty but Yogev et al. (2005) suggest increased gait variability 
during dual-tasking may explain some of the high fall risk in Parkinson’s disease patients. 
Gait variability during usual walking is independently associated with fall risk in 
community living older adults (Hausdorff et al., 1997; Maki, 1997), Alzheimer’s disease 
patients (Nakamura et al., 1996) and Parkinson’s disease patients (Hausdorff et al., 2001, 
Schaafsma et al., 2003). Increased gait variability in MS patients while walking and talking 
may therefore increase fall risk.  
Raising awareness, among both professionals and people with MS, of potential 
walking and talking difficulties is important so that it is taken into account in everyday 
activities, clinical assessment and treatment planning. The study findings suggest that 
assessing walking ability alone will not necessarily relate to everyday walking ability, 
where people may be required to attend simultaneously to other tasks. Walking under dual-
tasking conditions should therefore be separately assessed. The study results also suggest a 
clinical challenge in assessing dual-tasking in MS. Dual-task decrements were not 
predicted by MS disease severity or years since diagnosis, and while general cognitive 
ability, fatigue and a high score on Question 9 of the CFQ are associated with dual-task 
decrements none of these are predictive of group membership. This suggests that dual-
tasking ability needs to be independently assessed. To date no clinical measures have been 
developed to do this. A paradigm where performance on walking and cognitive tasks under 
both single and dual task conditions is compared would suffice, though from a practical 
perspective this may not be ideal in clinical situations.    62 
Evans et al. (submitted) have described a rehabilitation programme that may lead to 
improvements in walking and talking in people with acquired brain injury. This presents 
the possibility of developing treatment strategies for walking and talking impairments in 
MS, but as with other treatments any effects may be time-limited in a degenerative 
neurological condition such as MS.  
Limitations 
The present study has several limitations. While power was sufficient to detect effect 
sizes that were medium to large as predicted, it was insufficient for two analyses where the 
effect size was smaller (small to medium) than predicted from studies with other 
neurological groups. In the present study the digit span task was scored by giving one point 
if an entire digit sequence (e.g. 5-6-1-7) was correct and zero points if any digit in the 
sequence was incorrect. Since an average of seven digit sequences was performed in each 
condition this made the scoring system less sensitive than preferable. In future studies a 
more sensitive scoring system might be preferable, for example giving one point for each 
digit in the correct place in a sequence.  
Future Work 
Since there are no published studies investigating walking and talking in MS the 
present study needs to be replicated. In addition to the comments above regarding 
limitations, future studies could explore the effect of manipulating task demand on dual-
task decrements, in order to determine if impairments are due to capacity issues or a 
divided attention deficit. Finally developing a practical clinical tool for the assessment of 
walking and talking ability must be a priority for future work.  
 
 
Conclusions 
Initial hypotheses that MS participants perform differentially poorly on walking and 
talking dual-tasks compared to healthy controls were confirmed. It is suggested that fatigue   63 
and general cognitive ability contribute to this. The role of task demand in dual-tasking 
deficits remains unclear and needs further investigation. Clinicians should independently 
assess dual-task walking in MS. Future studies should replicate the current findings and 
develop practical clinical tools to assess walking and talking ability.    64 
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Table 1 
Basic Demographics and Clinical Characteristics of Participants 
  MS participants 
       n=18 
Healthy participants 
n=18 
P value 
   Demographic variables       
      Age (years)    39.23 +   8.15        39.25 + 11.42    0.944 
      Gender 
         Female 
         Male 
 
  16 
    2 
 
  12 
   6 
 
 
  0.228 
      Years of education    15.06 +   2.9    16.82 +  1.78    0.051* 
       
  Clinical variables        
      WTAR score (Standard score)  105.22 + 14.40  114.18 +  8.97    0.043* 
      ACE-R score    91.17 +   6.49    96.70 +  2.64    0.002* 
      Assessed digit span      6.39 +   1.19      6.50 +  1.12    0.900 
   CFQ    53.50   (43-62)    35.00   (30-41)    0.004* 
      MFIS    44.00   (42-55)    14.00   ( 6-32)  <0.000* 
      HADS  
          Anxiety 
          Depression 
 
    8.28 +   3.79 
    6.50     (2- 9) 
 
    5.65 + 2.57 
    1.50   (0-4) 
 
  0.015* 
  0.001* 
      Number of falls in past six  
       months 
    0.83 +   1.2            0 + 0    0.003* 
      Time to walk 30 metres (after  
       experimental trials- before     
       experimental trials) 
    1.00     (0-5)      1.00  (0-3)    0.210 
          
  MS participants only       
      EDSS score      2.74 +  1.59     
      Years since diagnosis      4.00    (1-7)     
____________________________________________________________________________ 
Note. Values are mean + standard deviation, median (95% confidence intervals) or n.* Statistically 
significant difference for MS versus healthy participants. 
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Table 2 
Performance of MS and Control Participants for Each Task Alone and in Titrated and Fixed Demand Dual-Task Conditions 
Task  Participant Type  Digit Task 
(% correct) 
Walking Speed 
(cm/second) 
Swing Time Variability  
(%) 
Double Limb Support Time 
Variability (%) 
 
D
A-T 
 
 
D
A-F 
 
MS 
Healthy controls 
 
MS 
Healthy controls 
 
 
64.89 + 22.78 
70.78 + 19.56 
 
46.11 + 29.14 
61.22 + 20.91 
     
W
A  MS 
Healthy controls 
 
  108.76 + 15.75 
139.57 + 19.47 
3.03 (2.40 to 3.65) 
3.40 (2.75 to 4.55) 
5.65 (3.90 to 6.45) 
7.78 (5.65 to 9.90) 
 
W
+T   MS 
Healthy controls 
 
50.50 + 27.94 
67.94 + 23.03 
 99.57  + 16.10 
136.72 +19.63 
3.93 (3.05 to 4.60) 
3.23 (2.70 to 3.70) 
5.55 (3.20 to 10.00) 
7.38 (5.45 to 9.70) 
W
+F  MS 
Healthy controls 
29.28 + 26.57  
62.78 + 27.32 
 97.35  + 16.98 
135.74 + 19.28 
4.00 (2.75 to 6.35) 
3.00 (2.30 to 3.60) 
6.45 (4.25 to 9.20) 
6.93 (6.30 to 8.45) 
________________________________________________________________________________________________________________________________________ 
Note. Values for digit task and speed are  mean + standard deviation, values for swing time and double support time variability are median  (95% confidence 
intervals). Abbreviations: D
A-T , digit task alone-titrated demand; D
A-F, digit task alone-fixed demand; W
A, walking alone; W
+T, walking with titrated demand 
digit task; W
+F, walking with fixed demand digit task.  
 
7
0
  
Table 3 
Percentage Change in Performance from Single to Dual-Task for Titrated and Fixed Task Demand. 
Note For digit task and speed positive signs indicate a decrease in performance from single to dual task, whilst for swing time and double support time variability negative 
signs indicate a decrease in performance from single to dual task (i.e. an increase in variability). 
Task  Participant Type  Digit Task 
 
Walking Speed 
 
Swing Time Variability  
 
Double Limb Support  
Time Variability  
W
+T   MS 
Healthy controls 
 
14.39 + 22.44 
  2.83 + 21.89   
  8.62 + 6.67 
  1.57 + 3.55  
-29.51   (-57.58 to 06.02) 
  -4.46   (-13.00 to 32.29) 
 1.25  (-46.47 to 20.00) 
 2.85  (-25.83 to 32.86) 
P value 
Effect size (r) 
 
    0.127 
  0.26 
  0.001* 
  0.61 
  0.068 
  0.31 
  0.521 
  0.11 
 
W
+F  MS 
Healthy controls 
 
16.83 + 27.95 
-1.56 + 21.32   
 
10.72 + 6.65 
  2.12 + 4.83 
-18.94 (-100.00 to 25.00) 
   7.36   (-23.77 to 35.09) 
-6.07  (-64.29 to 9.66) 
 1.85  (-25.45 to 33.84) 
P value 
Effect size (r) 
 
    0.033* 
  0.36 
<0.000* 
  0.61 
  0.037* 
  0.35 
  0.239 
  0.20 
_______________________________________________________________________________________________________________________________________ 
Note. Values for digit task and speed are  mean + standard deviation, values for swing time and double support time variability are median  (95% confidence intervals).  
Abbreviations: W
+T, walking with titrated demand digit task; W
+F, walking with fixed demand digit task. * Statistically significant difference for MS  
7
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Table 4 
Combined Percentage Change in Performance from Single to Dual Task for Titrated and Fixed Demands for Cognitive Task Change and Each Gait 
Variable 
Note. Positive signs indicate a decrease in performance from single to dual task for all variables. 
Task  Participant Type  Walking Speed 
 
Swing Time Variability  
 
Double Limb Support Time  
Variability 
W
+T   MS 
Healthy controls 
 
11.50 + 11.29  
  2.41 + 11.27  
22.89  ( 05.09 to 44.06) 
  3.24  (-15.01 to 20.45) 
15.73 (  -8.21 to 40.26) 
 2.97  (-10.93 to 18.91) 
P value 
Effect size (r) 
 
  0.021* 
0.38 
 
0.044* 
0.34 
0.171 
0.23 
W
+F  MS 
Healthy controls 
 
13.80 + 13.99  
 -0.51 + 10.03  
19.91  ( 02.63 to 65.73) 
-9.31   (-16.50 to 13.93) 
20.45 (  -2.13 to 39.82) 
  0.75 (-19.84 to 13.10) 
P value 
Effect size (r) 
 
  0.002* 
0.49 
0.010* 
0.43 
0.051* 
0.33 
_______________________________________________________________________________________________________________________________________ 
Note.Values for speed are  mean + standard deviation, values for swing time and double support time variability are median  (95% confidence intervals). Abbreviations: 
W
+T, walking with titrated demand digit task; W
+F, walking with fixed demand digit task. * Statistically significant difference for MS versus healthy participants. 
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Table 5 
Correlation Between CFQ, MFIS, HADS-A, HADS-D, ACER, WTAR, Education and Decrement Scores 
  CFQ  CFQ 
Question 9^ 
MFIS 
 
HADS-A 
 
HADS-D  ACE-R  WTAR  Education 
Digit task   
                 W
+T     
                    P value 
 
                 W
+F 
                    P value 
 
 
 0.119 
 0.490 
  
 0.150 
 0.382 
 
-0.028 
 0.872 
 
-0.068 
 0.692 
 
 
0.120 
0.162 
   
0.238 
0.486 
 
  0.150 
  0.386 
  
  0.109 
  0.546 
 
  0.181 
  0.289 
 
  0.310 
  0.066 
 
-0.147 
 0.393 
 
-0.045 
 0.793 
 
 0.052 
 0.768 
 
-0.035 
 0.841 
 
-0.090 
 0.603 
 
-0.120 
 0.485 
 
Walking speed 
                 W
+T     
                    P value 
 
                 W
+F 
                    P value 
 
 
0.167 
0.332 
   
0.200 
0.243 
 
0.332 
0.048* 
 
0.320 
0.057 
 
 
0.209 
0.222 
   
0.387 
0.020* 
 
  0.228 
  0.182 
 
  0.194 
  0.256 
 
 
  0.173 
  0.313 
 
  0.136 
  0.427 
 
-0.187 
 0.274 
 
-0.385 
 0.020* 
 
-0.130 
 0.458 
 
-0.233 
 0.179 
 
-0.032 
 0.852 
 
-0.314 
 0.062 
_____________________________________________________________________________________________________________________________________________________ 
Note. Values are Pearson’s r. ^ CFQ Question 9 ‘Do you fail to hear people speaking to you when you are doing something else?’ Abbreviations: W
+T, walking with titrated demand digit 
task; W
+F, walking with fixed demand digit task. * Statistically significant correlation. 
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Table 6 
Correlation Between Measures of Disease Severity in MS Participants and Decrement Scores 
  Digit task   
                 W
+T     
 
Digit task 
                 W
+F 
 
Walking speed 
                 W
+T     
 
Walking 
                 W
+F 
 
EDSS score 
   P value 
0.278 
0.280 
-0.002 
 0.993 
0.069 
0.791 
-0.296 
 0.248 
Years since diagnosis 
   P value 
0.240 
0.337 
-0.207 
 0.410 
0.008 
0.974 
-0.069 
0.785 
___________________________________________________________________________________________________________ 
Note. Values are Pearson’s r. Abbreviations: W
+T, walking with titrated demand digit task; W
+F, walking with fixed demand digit task 
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Table 7 
Logistic Regression Analysis for Pooled Data from MS and Control Participants  
 
Predictor  B  S.E.  B  Wald’s X
2  df  P value  e
B 
(odds ratio) 
95% C.I. for  e
B 
 
W
+F  Decrement in  walking 
speed 
0.263  0.106  6.220  1  0.013  1.301  1.058 to 1.600 
MFIS score  0.096  0.036  7.312  1  0.007  1.101  1.027 to 1.180 
Constant  0.217  0.570  0.146  1  0.703  1.243  NA 
 
 
 
 
 
 
 
 
 
___________________________________________________________________________ 
Note. Cox and Snell R
2 = 0.546.  Nagelkerke R
2 = 0.728. Abbreviations: NA, not applicable. 
 
 
 
 
 
 
 
Test       X
2  df   P value 
Overall model evaluation 
     Omnibus tests of model coefficients  
 
 9.982 
 
1 
 
  0.002 
Goodness of fit test 
     Homer & Lemeshow 
 
 2.730 
 
7 
 
  0.909 
7
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Table 8 
The Observed and the Predicted Frequencies for MS Group or Control Group by Logistic Regression 
 
Observed 
Predicted 
MS group                                                            Control group 
Percentage correct 
MS group                             15                                                                                 3                    83.3 
Control group        2                                                                               16                    88.9 
Total      18                                                                               17                    86.1 
7
6
  
Figure Captions 
 
 
Figure 1. Performance of MS and control participants on (A) digit task % correct (B) 
walking speed (C)  swing time variability and (D) double support time variability in single 
task conditions and titrated and fixed demand dual-task conditions. 
 
Figure 2. The mean percentage change + SD in (A) digit task and (B) walking speed for 
MS and control participants for single task minus dual-task performance in both titrated 
and fixed demand conditions. Note. Positive signs indicate a decrease in performance from 
single to dual task i.e. fewer digit task correct or slower speed in dual-tasks compared to single 
tasks. 
 
Figure 3. The median percentage change +  95% CI in (A) swing time variability and (B) 
double support time variability for MS and control participants for single task minus dual-
task performance in both titrated demand and fixed demand conditions. Note. Negative signs 
indicate a decrease in performance from single to dual-task i.e. greater variability in dual-tasks 
compared to single tasks.
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Figure 1 (A & B) 
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Figure 1 (C & D) 
 
 
C Swing time variability 
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D Double support time variability 
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____________________________________________ 
Abbreviations. D
A-T , digit task alone-titrated demand; D
A-F, digit task alone – fixed  
demand; W
A,  walking alone; W
+T, walking with titrated demand digit task; W
+F, walking 
with fixed demand digit task. 
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Figure 2 
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Figure 3 
 
A Swing time variability 
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CHAPTER THREE 
 
ADVANCED PRACTICE I REFLECTIVE CRITICAL ACCOUNT 
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Advanced Practice I Reflective Critical Account: 
Learning to Make Decisions in Complex Clinical Situations 
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ABSTRACT 
 
Decision-making in complex situations where there is an absence of all the information is a 
key competency in doctoral training. Yet decision making in these circumstances can be 
extremely complex. This reflective account describes the process of learning to make these 
decisions  in  a  third  year  specialist  neuropsychology  placement.  The  account  describes 
relevant  learning  experiences,  my  changing  thoughts  and  feelings  about  my  practice 
through  the  course  of  the  placement,  and  the  influences  on  my  practice,  thoughts  and 
feelings. The subsequent reflective review dissects this learning process and relates it to 
relevant literature. The skills I developed through learning to make these judgments are 
related  to  National  Occupational  Standards  for  Psychologists.  The  key  learning  points 
relate to evaluating evidence, the assessment process, awareness of the limit’s of evidence 
and of my own competence, and managing the emotional impact of decision-making.  The 
utility of reflective practice is discussed.  
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CHAPTER FOUR 
 
ADVANCED PRACTICE II REFLECTIVE CRITICAL ACCOUNT 
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Advanced Practice II Reflective Critical Account: 
Working Psychologically in Teams 
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ABSTRACT 
 
Working with teams and developing team effectiveness are increasingly important parts of 
psychologists’ roles. In my current placement I am working in two mental health teams 
with very different team approaches and this has presented many learning opportunities.  I 
have therefore chosen to write this reflective account about ‘working psychologically with 
teams’.  Kolb’s  Theory  of  Experiential  Learning  is  used  to  reflect  on  key  learning 
experiences. Key learning points were about the process of becoming a team member, 
working psychologically with teams at several different levels, formulating team dynamics 
and thinking about the management of psychological services at systems level. The lessons 
I learned and the skills I developed are in line with National Occupational Standards for 
Psychology which describe the provision of psychological systems, services and resources 
as a key competency for psychologists. I discuss how I hope to use these skills and develop 
them further as a qualified clinical psychologist.  
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Manuscript Submission and Review 
The Journal of the International Neuropsychological Society uses online submission and 
peer review. Authors who are not able to submit their manuscripts online are asked to 
contact  the  editorial  office  at:  jins@unm.edu.  The  website  address  for  submissions  is: 
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website.  Prior  to  online  submission,  please  consult 
http:00www.ncbi.nlm.nih.gov0entrez0query.fcgi?db5mesh for 6 keywords or mesh terms 
that are different from words in the title. Accurate mesh terms will increase the probability 
that your manuscript will be identified in online searches. Please follow the instructions 
carefully  to  avoid  delays.  The  menu  will  prompt  the  author  to  provide  all  necessary 
information, including the manuscript category, the corresponding author including phone 
number,  fax  number  and  e-mail  address,  and  suggested  reviewers.  The  website  will 
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adhere to the following length requirements. Please provide a word count on the title page   91 
for  abstract  and  for  manuscript  (not  including  abstract,  tables,  figures,  or  references). 
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prior approval. 
 
Manuscript Preparation and Style 
The  entire  manuscript  should  be  typed  double-spaced  throughout  using  any  word 
processing  program.  Unless  otherwise  specified,  the  guideline  for  preparation  of 
manuscripts is the Publication Manual of the American Psychological Association (5th 
edition) except for references with 3 or more authors (see References section). This may be 
ordered  from:  APA  Order  Dept.,  750  1st  St.  NE,  Washington,  DC  20002-4242,  USA. 
Pages  should  be  numbered  sequentially  beginning  with  the  Title  Page.  The  Title  Page 
should contain the full title of the manuscript, the full names and affiliations of all authors, 
a contact address with telephone and fax numbers and e-mail address, and the word count 
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(see http:00www.ncbi.nlm.nih.gov0 entrez0query.fcgi?db5mesh for list), and they should 
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scientific  articles,  including  Regular  Research  Articles,  Brief  Communications,  Rapid   92 
Communications,  and  Symposia,  the  format  should  include  an  Abstract,  Introduction, 
Method, Results, and Discussion. This should be followed by References, Appendixes, 
Acknowledgments, Tables, Figures, and Figure Legends. The use of abbreviations, except 
those  that  are  widely  used,  is  strongly  discouraged.  They  should  be  used  only  if  they 
contribute to better comprehension of the manuscript. Acronyms should be spelled out at 
first mention. Metric system (SI) units should be used. 
 
Figures 
High quality digital images (600 dpi or higher) should be provided in PDF, EPS, or TIFF 
formats. If a digital image is not available, please scan in the image. Figures should be 
numbered consecutively as they appear in the text. Any indication of features of special 
interest should also be included. Figures should be drawn or composed on computer to 
about twice their intended final size and authors should do their best to construct figures 
with notation and data points of sufficient size to permit legible photo reduction to one 
column of a two-column format. As a guide, no character should be smaller than 1 mm 
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ABSTRACT 
 
Background:  Up  to  50%  of  individuals  with  MS  experience  some  level  of  cognitive 
impairment  and  this  can  contribute  to  the  disability  experienced  in  everyday  life.  One 
cognitive  domain  frequently  thought  to  be  impaired  in  MS  is  attention,  in  particular 
divided attention. The present study seeks to investigate divided attention in people with 
MS using a dual-task paradigm.  
Aims: The aim of the study is to investigate dual-tasking, doing two things at once, in MS, 
specifically  ‘walking  while  talking’.  It  is  hoped  that  the  findings  will  add  to  the 
understanding  of  divided  attention  in  MS  as  well  as  to  the  general  understanding  of 
cognition-motor relationships. 
Methods: Both MS participants and controls will perform cognitive tasks and motor tasks 
under  both  single  and  dual  task  conditions.  It  is  hypothesised  that  walking  will  be 
differentially  impaired  while  performing  concurrent  cognitive  tasks  in  MS  participants 
compared to controls. 
Applications:  Since  impairment  of  both  attention  and  mobility  appear  to  effect  a 
significant number of people with MS an investigation of cognitive–motor interference 
may have practical implications for assessment and rehabilitation in MS, as well as adding 
to the general understanding of divided attention in the brain. 
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INTRODUCTION 
Multiple Sclerosis (MS) is the most common neurological disease affecting  young and 
middle  aged  adults  (Arnett,  2003).  The  impairments  arising  from  MS  can  lead  to 
significant disability. MS is estimated to cost in the region of 1.4 billion GBP per annum in 
the UK (Kobelt et al., 2000), compared with an estimated 7 billion per annum for stroke 
(National Audit Office, 2005), which has a prevalence of 700 per 100, 000 (NICE, 2004).  
 
Physical  impairments  in  MS  include  impairment  to  sensory  and  motor  systems,  with 
problems with fatigue and mobility common. Cognitive impairment is thought to affect 
about  50%  of  people  with  MS  (NICE,  2004).  The  most  frequently  impaired  cognitive 
domains in MS are memory, mental flexibility, visuo-construction, information processing 
speed and attention (Calabrese, 2006).  
 
When  surveyed  22-25%  of  people  with  MS  report  impairment  of  attention  (Sullivan, 
Edgley & Dehoux, 1990 & Arnett, 2003), though there appear to be only a few studies 
investigating attention in MS (Calabrese, 2006). In a recent review of neuropsychological 
impairment in MS, Calabrese (2006) concluded that impairment of attention appears to 
occur early in the disease course and may be one reason for subsequent dysfunction in 
memory and abstract reasoning. McCarthy et al. (2005) investigated the performance of 
MS and control participants on measures of divided and sustained attention. The results 
suggested that MS participants were slower and less accurate on both measures of attention 
compared  to  controls  and  that  divided  attention  was  more  impaired  than  sustained 
attention. D’Esposito et al. (1996) used a dual-task paradigm with people with MS, asking 
participants to perform two cognitive tasks simultaneously in the dual-task condition. They 
found that the MS participant’s had greater decrement in performance in the dual-task 
compared to healthy controls, suggesting a differential impairment in divided attention.  
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Dual-tasking refers to the ability to do two things at once. Investigations using a dual-task 
paradigm further our understanding of both the organisation of cognitive resources in the 
brain  (Della  Sala  &  Logie,  2001)  and  the  effect  of  neurological  conditions  such  as 
Alzheimer’s disease, stroke, brain injury and Parkinson’s disease on divided attention. This 
understanding is important because if one’s ability to do two things at once is impaired 
then this has implications for people’s ability to function in everyday life where one is 
frequently required to attend to more than one thing at any one time.  
 
The  control  of  posture  and  gait  has  traditionally  been  considered  automatic  or  reflex 
controlled, requiring minimal attentional resources (Woollacott & Shumway-Cook, 2002). 
A  recent  review  suggests  that  control  of  walking  can  be  attentionally  demanding 
(Woollacott  &  Shumway-Cook,  2002).  In  healthy  young  adults  this  dual-task  effect 
appears to be small and is detectable only when quite complex additional secondary tasks 
are performed, while in healthy older adults performing a dual-task appears to have a more 
deleterious effect. 
 
Recent studies have investigated the effect of performing concurrent cognitive tasks on 
walking  in  adults  with  various  neurological  conditions.    Studies  of  people  with 
Alzheimer’s (Cocchini et al., 2004) and Parkinson’s disease (Yogev et  al., 2005) have 
suggested that speed and accuracy in walking is affected by simultaneously performing a 
cognitive  task.  The  research  suggests  that  in  these  neurological  conditions  performing 
concurrent tasks has a disproportionate effect on walking, compared to healthy controls 
(Woollacott & Shumway-Cook, 2002).  
 
One  possible  reason  why  a  concurrent  cognitive  task  may  impact  on  walking  is  that 
performing two tasks simply reflects an increase in task demand and once this demand 
exceeds attentional capacity a decrement in performance on one of the tasks occurs. In   103 
neurological conditions one might expect that this attentional capacity is reduced making it 
more likely that a dual-task performance decrement will occur. An alternative explanation 
is that that performing two tasks makes demands on divided attention and that in these 
neurological conditions there is damage to some executive co-ordination function required 
to divide attention between concurrent demands (Logie et al., 2004). It has been argued 
(e.g. Cocchini et al., 2004 & Logie et al., 2004) that in studying dual-tasking it is important 
to  control  for  this  task demand  effect  when  comparing  a  patient  group  with  a  healthy 
control  group.  In  order  to  determine  whether  dual-tasking  difficulties  are  specifically 
caused  by  a  divided  attention/dual-tasking  process  impairment  they  suggest  that  it  is 
necessary to titrate tasks according to performance under single task conditions. This has 
the advantage of making it clearer whether a divided attention deficit is responsible for 
difficulties under dual-tasking conditions, though may be less clinically relevant to the 
extent that everyday conditions are not titrated to individual performance levels. 
 
Regardless of the reason for dual-tasking difficulties there are implications for everyday 
life. It has been suggested that difficulty doing two things at once may explain the high risk 
of falls in Alzheimer’s disease (Cocchini et al., 2004) and may have implications for the 
assessment  and  rehabilitation  of  walking  in  physiotherapy  settings  in  a  brain  injured 
population (Haggard et al., 2000). The present study seeks to investigate the effects of 
performing a simultaneous cognitive task when walking in MS. This has not previously 
been investigated in a MS population but the procedures have been widely used with other 
neurological populations. Since impairment of both attention and mobility appear to affect 
a significant number of people with MS an investigation of cognitive–motor interference 
may have practical implications for assessment and rehabilitation in MS, as well as adding 
to the understanding of divided attention in MS. In order to determine whether dual-tasking 
difficulties are specifically caused by a divided attention/dual-tasking process impairment 
both a fixed and a titrated demand task will be used.   104 
AIMS AND HYPOTHESES 
Aims 
￿  To investigate whether cognitive-motor dual-tasking is impaired in MS 
￿  To investigate whether any cognitive-motor dual-tasking impairment in  MS is a result 
of increased task demand or whether it is a divided attention impairment 
￿  To add to the understanding of cognition-gait relationships 
 
Hypotheses 
It  is  expected  that  MS  participants  will  perform  differentially  poorly  on  dual-tasks 
compared  to  controls.  Specifically  it  is  hypothesised  that  walking  and  an  additional 
cognitive  task  will  be  disproportionately  impaired  in  dual-task  conditions  compared  to 
single task conditions (in MS participants compared to controls).  
 
PLAN OF INVESTIGATION 
Participants 
Participants will be individuals with MS and, consistent with previous studies of dual-
tasking in neurological conditions, a control group of healthy individuals. The purpose of 
the control group is to compare the effect of dual-task conditions on walking in those with 
and without MS. Previous studies, as mentioned above, have found that the performance of 
healthy controls decreases under dual-task conditions, but that this performance decrement 
is  significantly  smaller  than  that  found  in  the  various  neurological  conditions  studied. 
Inclusion  of  a  control  group  allows  one  to  evaluate  any  dual-task  decrement  in  MS 
participant’s  performance  in  light  of  the  performance  of  healthy  controls,  making  it 
possible to consider what dual-task decrement is normal and what may be attributed to MS. 
 
A control group of individuals with orthopaedic conditions was considered, as this would 
allow  one  to  control  for  musclo-skeletal  contributions  to  dual-task  performance   105 
decrements. This consideration was discounted however. First obtaining an orthopaedic 
control group would present practical difficulties in the timeframe available. In addition it 
would be difficult to ascertain what was an appropriate orthopaedic control, for example 
how the level of physical impairment in the MS group (which in this study would be mild 
due to the inclusion criteria) could be matched to levels of impairment in an orthopaedic 
group. Second since there is very little previous dual-task research with MS it was thought 
preferable to first compare MS participants with healthy participants to establish whether 
MS participants dual-task performance decrement is greater than that of healthy controls. 
The key issue is a clinical one, i.e. whether dual-tasking is a difficulty in an MS population 
compared to a healthy one, regardless of the contribution of physical and cognitive factors 
to this. As the first study to investigate cognitive-motor dual-tasking in an MS population, 
it  was  considered  preferable  to  first  establish  whether  there  is  a  cognitive-motor  dual-
tasking problem in this population. 
 
Inclusion & Exclusion Criteria 
MS  participants  will  be  included  if  they  meet  the  following  criteria;  a  diagnosis  of 
relapsing-remitting sub-type of MS and an Expanded Disability Status Scale (EDSS) score 
(Kurtzke,  1983)  up  to  5.5.  Relapsing-remitting  MS  refers  to  clearly  defined  disease 
relapses with full recovery or with sequelae and residual deficit upon recovery; periods 
between  relapses  are  characterised  by  a  lack  of  disease  progression  (NICE,  2004).  An 
EDSS  score  up  to  5.5  includes  individuals  with  mild  and  moderate  MS.  It  indicates 
minimal or moderate impairment in up to 4 functional systems and an ability to walk at 
least 100 meters unaided. A Consultant Neurologist will assess patients using the EDSS 
and confirm their ability to do the physical demands of the task.  
 
Healthy  controls  will  be  matched  for  age  and  pre-morbid  ability  as  described  below. 
Individuals, either MS participants or healthy controls, with major psychiatric disorder will   106 
be excluded otherwise anxiety and depression will be screened for (see under ‘Measures’ 
below). Individuals with a history of brain injury or neurological disease (other than MS) 
will be excluded. Individuals with a history of falls in the past month will be excluded. 
 
Recruitment Procedures 
Recruitment of MS participants will be undertaken in conjunction with Dr. Colin O’Leary, 
Consultant  Neurologist  at  the  Neurology  Department  in the  Southern General  Hospital 
(SGH),  Glasgow.  Potential  MS  participants  will  be  identified  by  the  neurologist  in 
outpatient appointments and provided with an information pack about the study. After two 
weeks  a  Research  Nurse  unconnected  with  the  study  will  contact  those  provided  with 
information packs to determine if they wish to take part. Individuals who wish to take part 
will then be contacted by the researcher, Fiona Hamilton. Controls will be recruited by 
including  requests  for  suitable  controls  in  information  packs  to  MS  participants.  It  is 
anticipated that controls will therefore be relatives and friends of MS participants.  
 
Measures 
The screening measures described below will be used. The purpose of these measures is to 
ensure  participants  meet  the  inclusion  criteria  (EDSS),  to  adequately  describe  the 
population being studied, to match participants and controls (WTAR) and to identify any 
association between self-reported attentional difficulties (CFQ) and dual-task performance 
and self-reported fatigue (MFIS) and dual-task performance in the current study. 
 
Pre-morbid ability:     Weschler Test of Adult Reading (WTAR) (Weschler, 
         2001).   
General cognition:    Addenbrooke’s Cognitive Examination (ACE)  
         (Mathuranath, 2000).  
Vision :      The Cortical Vision Screening Test (CVST) (James,    107 
        Plant & Warrington, 2001). 
Anxiety & depression:  Hospital Anxiety and Depression Scale (HADS) 
        (Zigmund & Snaith, 1983). 
Fatigue  Modified Fatigue Impact Scale (MFIS) (Multiple Sclerosis 
Council for Clinical Practice Guidelines, 1998) 
Self-rated attention:  Cognitive Failures Questionnaire (CFQ) (Broadbent, 1982). 
Disease severity:  Kurtzke Expanded Disability Status Score (EDSS)  
(Kurtzke,  1983)  and  Multiple  Sclerosis  Functional 
Composite  Scale  (Cutter  et  al..,  1999).  These  will  be 
completed by the neurologist. 
Demographic information:  Age, gender, history of brain injury or neurological disease, 
disease  type  (MS  participants)  and  years  of  illness  (MS 
participants). 
 
Dependent and independent variables will be measured as follows; 
Walking 
Previous studies have used both simple and computerized systems for measuring walking 
and  gait,  though  these  studies  were  conducted  in  other  neurological  populations.  After 
consulting  with  physiotherapists  and  a  bioengineer  with  interests  in  dual-tasking  the 
GAITRite System for measuring walking parameters was chosen. The GAITRite system in 
a flexible electronic walkway providing an automated means of measuring the spatial and 
temporal parameters of gait using a carpet embedded with sensors which detect footfalls.  
It has been shown to give valid and reliable data (van Uden & Besser, 2004).  The carpet is 
457cm long with an active area of 366cm and a sampling rate of 32.3-38.4Hz.  Walking 
speed, step length, step frequency, step time and double limb support time variability will 
be automatically calculated by computer software designed for GAITRite and recorded on 
disc for later analysis.   108 
 
First  participants  will  be  assessed  for  risk  of  falls.  A  timed  test  of  balance  will  be 
completed for each participant. Participants will be asked to perform a single leg stance on 
each leg and tandem stance with right and left leg in front.  Ability to maintain position 
without losing balance for up to 30s will be recorded.    
 
For each trial participants will be asked to walk unaided around a circuit of approximately 
25m at their preferred walking speed continuously for 90 seconds.  Distance walked will 
be  one  measure  of  walking.  This  duration  was  chosen  1)  to  ensure  that  total  distance 
walked does not exceed 100 metres, since ability to walk at least 100 metres is part of the 
inclusion criteria, 2) so as not to induce significant fatigue and 3) this time length was 
thought long enough to induce a dual-tasking effect since it has been used in several other 
studies. In order to ensure that difficulties initiating walking do not influence the results 
timing of walking will commence after the individual has walked 5 metres (as in Cocchini 
et al., 2004). An instrumented walkway (GAITRite) will be used to collect data on gait 
parameters as outlined above.  It will be placed so that it forms part of the circuit and 
positioned so that individuals do not initiate and terminate walking immediately before and 
after it in order to avoid the effects of acceleration and deceleration.  It is anticipated that 
participants will perform up to 4 continuous repetitions of the circuit during each trial 
resulting in a maximum of 20 repetitions over the walkway.  A rest will be given between 
each trial to avoid the effects of fatigue.  Data will be stored on disc for later analysis.  
Immediately before and after the protocol, baseline walking speed will be measured using 
the  10m  walk  test  during  which  subjects  perform  3  repetitions  of  the  10m  walk  to 
determine any impact of fatigue on gait performance.   
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Cognitive tasks 
We propose to use two cognitive tasks and to compare performance under single and dual 
task conditions (i.e. when paired with walking) for each task. An important distinction is 
that between tasks where difficulty is titrated according to the individual’s performance in 
single task performance, so that the dual-task is a ‘true’ measure of the ability to do two 
things at once rather than merely representing an increase in task demand, and tasks where 
the dual-task has a fixed demand. One task will be a fixed demand task (i.e. same task for 
all participants) and the other will be a titrated task where the form of the task used will be 
titrated in terms of each participant’s level of performance under single task conditions.  
 
The fixed demand task will be a fixed digit span task. Participants will listen to sequences 
of digits, played aloud on a CD player, and will be required to repeat each sequence in 
order. All participants will be presented with sequences that are seven digits in length, 
since this is the average digit span in adults (Miller, 1956). The dependent variable will be 
percentage of digits correctly recalled in the correct position in one minute. 
 
The titrated task will involve a digit span task that under dual-task conditions is titrated to 
the individual’s level of single task ability. The titration procedures  are those used by 
Cocchini  et  al.  (2004)  and  Logie  et  al.  (2004).  First  a  digit  recall  assessment  will  be 
performed. The participant will listen to sequences of digits and will be required to repeat 
each sequence. The sequence of digits will be increased in length by one digit at a time 
until the participant fails two out of three sequences of a particular length. Digit span will 
be taken to be one digit less than the length at which the individual failed (e.g. if the 
participant was successful at length six but failed two out of three sequences at length 
seven  then  their  digit  span  would  be  considered  to  be  sequence  length  six).  Once  an 
individual’s digit span is ascertained the titrated digit span task will consist of listening to 
sequences of digits at their span length for immediate serial ordered recall. Digit sequences   110 
will be played aloud on a CD player. The dependent variable will be percentage of digits 
correctly recalled in the correct position in one minute. 
 
Design 
The design will involve comparing performance people with MS and healthy controls in 
terms of decrement from single to dual task conditions for the walking task and the two 
cognitive tasks.  
 
Research Procedures 
All  participants  will  complete  the  digit  span  titration  assessment  before  completing 
experimental trials. Experimental trials will involve participants completing both motor 
and  cognitive  tasks  in  single  task  conditions  for  the  purpose  of  control.  Motor  and 
cognitive tasks will then be combined in dual-task conditions. In total this means each 
participant will complete 5 trials; walking alone, fixed digit task alone, titrated digit task 
alone, walking with fixed digit task and walking with titrated digit task. Each trial will last 
a maximum of 90 seconds. Trials will be counter-balanced to take account of order effects. 
Counter-balancing will be blocked to ensure two walking tasks do not occur together, this 
is to control for fatigue effects. Table 1 overleaf outlines the different permutations of 
counter-balancing. All experimental trials will be videotaped to assist scoring of walking 
and digit span tasks.  
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Table 1 outlining counter-balancing of trials 
Permut-
ation 
Trial 1  Trial 2  Trial 3  Trial 4   Trial 5 
1  Walking 
alone 
Fixed digit 
task alone 
Fixed digit 
& walking 
Titrated 
digit task 
alone 
Titrated 
digit & 
walking 
2  Walking 
alone 
Fixed digit 
task alone 
Titrated 
digit & 
walking 
Titrated 
digit task 
alone 
Fixed digit 
& walking 
3  Walking 
alone 
Titrated 
digit task 
alone 
Fixed digit 
task & 
walking 
Titrated 
digit task 
alone 
Titrated 
digit & 
walking 
4  Walking 
alone 
Titrated 
digit task 
alone 
Titrated 
digit & 
walking 
Fixed digit 
task alone 
Fixed digit 
task & 
walking 
 
Sample Size 
Studies of divided attention have found large effect sizes when two cognitive tasks have 
been  examined  (e.g.  D'Esposito  (1996)  d=0.79  (N=51)  with  MS  patients)  and  when  a 
cognitive task and motor task have been combined (e.g. Camiocioli (1997) d= 0.73 and 
d=0.83  (N=38)  and  Cocchini  et  al.  (2004)  d=  0.86  (N=30),  both  with  patients  with 
Alzheimer’s disease). In the absence of studies investigating cognitive-motor dual-tasking 
in  MS  effect  size  will  be  estimated  based  on  cognitive-motor  dual-tasking  studies  in 
Alzheimer’s  disease.  Assuming  a  similar  effect  size  for  cognitive-motor  dual-task 
combinations in MS would suggest that for alpha 0.05 (two tailed), power =0.8, a sample 
size of n=26 per group would be needed, or for alpha =0.05 (1 tailed), n=20 per group. In 
order to allow for potential drop-outs 25 people per group will be recruited.    112 
Settings & Equipment 
The  Gait-Rite  System  will  be  borrowed  from  Glasgow  Caledonian  University,  for  the 
purpose of the study.  Blank CD’s will be required to record digit span sequences. A CD 
player will be needed to play the CD’s for the cognitive task. A video-recorder will be 
required to tape experimental trials. The research will be conducted in a movement lab at 
the  Southern  General  Hospital.  This  space  will  be  provided  by  Glasgow  Caledonian 
University. 
 
Data Analysis 
The  dependent  variables  will  be  performance  decrement  from  single  to  dual-task 
conditions for the walking task and the two cognitive tasks. A composite decrement score 
averaging the decrement on the walking and cognitive tasks (walking and fixed digit task; 
walking and titrated digit task) will be calculated. Independent variable will be participant 
group (MS participants and healthy controls). If standard assumptions are met, t-tests will 
be used to compare means.  
 
Secondary correlational analysis of dual-task decrement score and the Cognitive Failures 
Questionnaire score will be performed. This analysis is designed to evaluate whether dual-
task  performance  decrement  correlates  with  self-reported  dual  tasking  and  general 
attentional  difficulties  in  everyday  life.  A  secondary  correlational  analysis  of  dual-task 
decrement score and the Modified Fatigue Impact Scale Score will be performed in order 
to assess whether individuals who experience greater fatigue on a day-to-day basis have 
greater difficulties with cognitive motor dual-tasking. 
 
 
 
   113 
HEALTH AND SAFETY ISSUES 
Researcher Safety Issues 
There are no apparent risks to the researcher from carrying out this study. The study will 
be carried out in a hospital setting that the participants routinely attend and where there are 
health and safety procedures in place. The patient group is not known to be aggressive. The 
research procedures are not known to cause significant distress. 
 
Participant Safety Issues 
One possible risk is a risk of MS participants falling while walking since this is a group 
with  some  physical  limitations.  This  will  be  addressed  by  the  inclusion  criteria,  of  an 
EDSS score of less than 5.5, which sets a safe level of physical impairment for inclusion 
and will be judged by the neurologist. Participants will also be asked as part of the initial 
screening if they have fallen within the past month. Regular fallers will be excluded.  
Risk  of  falls  will  be  identified  by  the  use  of  screening  and  the  timed  balance  test  as 
outlined in the method section. When walking participants will be issued with instructions 
regarding what to do if they think they may fall, these instructions will be based on advice 
from  the  physiotherapist.  The  researcher  will  walk  a  couple  of  steps  behind  each 
participant as they complete walking tasks.  In addition the research will be conducted in a 
hospital setting that participants routinely attend where procedures are in place to minimize 
risk and where medical help is readily available.  
If a participant falls the following procedure will be adhered to, this is based on the NHS 
GG&C Falls Management Policies & Guidelines (2006). If there is no obvious injury or 
discomfort the participant will be moved to a safe place to rest, such as seating in the gait 
lab. If there is obvious injury or the participant complains of discomfort the participant will 
be referred to medical staff for assessment. In either case an incident/accident form will be 
completed.   114 
ETHICAL ISSUES 
It will be necessary to ensure that the procedures to approach and recruit participants are 
free  from  any  pressure  to  participate.  Participants  will  be  provided  with  adequate 
information  to  make  an  informed  decision  to  participate  including;  the  purpose  of  the 
study, what would be involved in taking part (including time), any benefits or risks to 
taking  part,  the  option  to  withdraw  at  any  time,  whether  participant  expenses  will  be 
covered (e.g. travel expenses) and that participation or non-participation will not effect 
their medical treatment at the hospital.  In addition participants will be briefed on how 
information obtained will be used  and that their individual results remain confidential. 
Steps will be taken to ensure data are safely stored in a confidential manner and in the data 
analysis stages, anonymous. Research procedures will be designed to ensure the safety of 
the participants (see Health & Safety Issues above).  
 
Ethical & Management Approval Submissions 
Ethics  application  will  be  made  to  the  SGH  ethics  committee.  Dates  for  committee 
meetings are as follows: 
 
 
 
 
 
 
Application will also be made to the NHS Management Approval System; this will include 
a Health & Safety Assessment.  
 
 
 
Date of Meeting  Cut off date for meeting 
16.01.2007  04.01.2007 
27.02.2007  13.02.2007 
27.03.2007  13.03.2007 
24.04.2007  10.04.2007 
29.05.2007  15.05.2007 
26.06.2007  12.06.2007 
31.07.2007  17.07.2007   115 
FINANCIAL ISSUES 
See Appendix for breakdown of estimated costs. 
 
TIMETABLE 
A provisional timetable is as follows: 
January –March 2007:  
￿ Prepare  and  submit  Draft  MRP  Proposal  and  full  MRP  Proposal;  including 
finalizing research design and procedures 
￿ Initiative Research Logbook 
￿ Prepare and submit Systematic Review Outline 
￿ Sit in on Neurology clinics for MS patients at SGH 
￿ Consult with Physiotherapy Department at SGH re: measures of gait and possible 
space for performing study 
April-July 2007 
￿ Prepare and submit ethics and management approval submissions 
￿ Source and finalise research  and recruitment procedures,  space and materials on 
site 
￿ Finalize planned statistical analysis of data 
August-September 2007 
￿ Begin participant recruitment 
October-December 2007 
￿ Data collection 
￿ Research Progress Meeting 
January-April 2008 
￿ Data Collection 
￿ Research Progress Meeting 
April-May 2008   116 
￿ Data analyses 
￿ Research Progress Meeting 
June-July 2008 
￿ Submit MRP drafts to supervisor 
￿ Bind and submit MRP  
 
PRACTICAL APPLICATIONS 
It is hoped the findings of the study will have practical implications for assessment and 
rehabilitation  of  cognitive-motor  dual-tasking  in  MS,  as  well  as  adding  to  the  general 
understanding of divided attention and cognition-motor relationships in the brain. There is 
anecdotal evidence that cognitive-motor dual-tasking may be an issue in this population, 
for example clinicians report that patients often stop walking while they are talking to 
them.  In  addition,  in  other  neurological  populations  cognitive-motor  dual-tasking 
difficulties have been linked to risk of falls (Cocchini et al., 2004). In particular it is hoped 
the findings of the study will further understanding of everyday functioning in MS as many 
everyday activities require dual-tasking, such as walking while talking and walking while 
negotiating  a  busy  environment  with  many  distractions,  e.g.  crossing  the  street.  It  is 
possible  that  people  with  MS  avoid  these  situations  for  fear  of  falling  or  becoming 
unsteady. It is hoped that the current study will identify if cognitive-motor dual-tasking is a 
common problem in MS populations, identify if cognitive-motor dual-tasking problems 
can  be  assessed  and  suggest  whether  there  is  potential  for  rehabilitation  strategies  to 
address this issue. 
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Appendix C2: Individual Digit Span Assessment 
     
Digits  Answer 
6-1   
1-9   
3-5   
5-1-9   
4-5-2   
6-3-1   
2-9-1-5   
6-5-1-9   
8-5-4-7   
8-2-9-6-1   
5-8-7-4-9   
4-1-8-7-2   
4-5-3-8-6-2   
3-9-5-2-4-6   
9-7-8-1-2-6   
4-3-6-7-1-2-5   
5-9-8-4-6-1-2   
3-4-1-6-5-8-2   
3-5-8-7-2-6-4-1   
6-2-7-1-4-5-6-9   
4-9-8-2-7-3-1-5   
5-2-1-4-7-3-6-9-8   
4-1-8-7-2-3-9-5-6   
3-6-5-9-2-4-7-1-8   
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Appendix C3: Description of Development of Digit Span Task 
 
Digit sequences of lengths varying from two digits to ten digits long were generated using 
Microsoft Word Excel random numbers function. A CD was compiled with 18 tracks. On 
each track the researcher was recorded reading digit sequences of a particular length for 90 
seconds. The digits in each sequence were read at the rate of one per second. After each 
digit sequence was read there was a pause for the participant response before the next digit 
sequence was read. Two different tracks were recorded at each digit sequence length (i.e. 
two tracks where all sequences were two digits long, two tracks where all sequences were 
three digits long etc). 
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Appendix C4: Definitions of Swing Time and Double Support Time and Overview of 
Gait Cycle 
Figure: Timing During a Single Gait Cycle (from Whittle, 2007, page 54) 
 
 
Stance Phase: Part of the gait cycle for one side in which the foot is on the ground (from 
Whittle, 2007, page 240). 
Swing Phase: Part of the gait cycle for one side in which the foot is off the ground, 
moving through the air (from Whittle, 2007, page 240). 
Double Support Time: Period in the gait cycle in which both feet are on the ground (from 
Whittle, 2007, page 235). 
Swing Time: Duration of the swing phase, between toe off and initial contact (from 
Whittle, 2007, page 240). 
Initial Contact: Event in the gait cycle when first contact is made between the foot and the 
ground, made by the heel in normal gait (from Whittle, 2007, page 236). 
Toe Off: Event in the gait cycle when the foot (generally the toe) leaves the ground (from 
Whittle, 2007, page 240).    81   81  
 